Project
Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Navigation
Downloads
Results for PATZ1_KLF4
Z-value: 1.94
Motif logo
Transcription factors associated with PATZ1_KLF4
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
PATZ1
|
ENSG00000100105.13 | POZ/BTB and AT hook containing zinc finger 1 |
|
KLF4
|
ENSG00000136826.10 | Kruppel like factor 4 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| PATZ1 | hg19_v2_chr22_-_31741757_31741770 | -0.73 | 3.9e-06 | Click! |
| KLF4 | hg19_v2_chr9_-_110251836_110251927 | 0.26 | 1.6e-01 | Click! |
Activity profile of PATZ1_KLF4 motif
Sorted Z-values of PATZ1_KLF4 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr6_-_4135693 | 23.77 |
ENST00000495548.1
ENST00000380125.2 ENST00000465828.1 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr6_-_4135825 | 22.87 |
ENST00000380118.3
ENST00000413766.2 ENST00000361538.2 |
ECI2
|
enoyl-CoA delta isomerase 2 |
| chr8_-_144651024 | 19.73 |
ENST00000524906.1
ENST00000532862.1 ENST00000534459.1 |
MROH6
|
maestro heat-like repeat family member 6 |
| chr19_-_15344243 | 14.42 |
ENST00000602233.1
|
EPHX3
|
epoxide hydrolase 3 |
| chr19_-_51472031 | 14.38 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_+_35645817 | 13.92 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr9_-_139891165 | 13.15 |
ENST00000494426.1
|
CLIC3
|
chloride intracellular channel 3 |
| chr1_+_65886244 | 12.79 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
| chr10_-_15210615 | 12.78 |
ENST00000378150.1
|
NMT2
|
N-myristoyltransferase 2 |
| chr11_-_568369 | 12.50 |
ENST00000534540.1
ENST00000528245.1 ENST00000500447.1 ENST00000533920.1 |
MIR210HG
|
MIR210 host gene (non-protein coding) |
| chr19_+_35645618 | 12.46 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
| chr19_-_55658687 | 12.09 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_-_9189229 | 12.06 |
ENST00000377411.4
|
GPR157
|
G protein-coupled receptor 157 |
| chr8_+_86376081 | 11.66 |
ENST00000285379.5
|
CA2
|
carbonic anhydrase II |
| chr10_-_15210666 | 11.50 |
ENST00000378165.4
|
NMT2
|
N-myristoyltransferase 2 |
| chr19_-_51504852 | 11.21 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
| chr22_+_38071615 | 11.09 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
| chr19_-_51472222 | 11.06 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_51487071 | 11.02 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
| chr14_+_94640633 | 10.67 |
ENST00000304338.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr19_-_51504411 | 10.56 |
ENST00000593490.1
|
KLK8
|
kallikrein-related peptidase 8 |
| chr19_-_15343773 | 10.53 |
ENST00000435261.1
ENST00000594042.1 |
EPHX3
|
epoxide hydrolase 3 |
| chr2_-_241396131 | 10.50 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
| chrX_-_153599578 | 10.42 |
ENST00000360319.4
ENST00000344736.4 |
FLNA
|
filamin A, alpha |
| chr10_-_75634219 | 10.33 |
ENST00000305762.7
|
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr2_+_95691417 | 10.26 |
ENST00000309988.4
|
MAL
|
mal, T-cell differentiation protein |
| chr21_-_47648665 | 10.20 |
ENST00000450351.1
ENST00000522411.1 ENST00000356396.4 ENST00000397728.3 ENST00000457828.2 |
LSS
|
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
| chr9_+_131182697 | 10.14 |
ENST00000372838.4
ENST00000411852.1 |
CERCAM
|
cerebral endothelial cell adhesion molecule |
| chr19_-_51456198 | 9.83 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
| chr9_-_123639304 | 9.71 |
ENST00000436309.1
|
PHF19
|
PHD finger protein 19 |
| chr1_-_109825751 | 9.55 |
ENST00000369907.3
ENST00000438534.2 ENST00000369909.2 ENST00000409138.2 |
PSRC1
|
proline/serine-rich coiled-coil 1 |
| chr1_+_150522222 | 9.37 |
ENST00000369039.5
|
ADAMTSL4
|
ADAMTS-like 4 |
| chr19_+_54371114 | 9.35 |
ENST00000448420.1
ENST00000439000.1 ENST00000391770.4 ENST00000391771.1 |
MYADM
|
myeloid-associated differentiation marker |
| chr22_+_31477296 | 9.35 |
ENST00000426927.1
ENST00000440425.1 ENST00000358743.1 ENST00000347557.2 ENST00000333137.7 |
SMTN
|
smoothelin |
| chr1_-_20812690 | 9.32 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
| chr19_-_55658650 | 9.27 |
ENST00000589226.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr1_-_109825719 | 9.26 |
ENST00000369904.3
ENST00000369903.2 ENST00000429031.1 ENST00000418914.2 ENST00000409267.1 |
PSRC1
|
proline/serine-rich coiled-coil 1 |
| chr6_-_30654977 | 9.25 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
| chr19_-_51456344 | 9.16 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
| chr6_+_37137939 | 9.06 |
ENST00000373509.5
|
PIM1
|
pim-1 oncogene |
| chr2_-_241396106 | 9.03 |
ENST00000404891.1
|
AC110619.2
|
Uncharacterized protein |
| chr19_-_51456321 | 8.91 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
| chr19_+_8429031 | 8.63 |
ENST00000301455.2
ENST00000541807.1 ENST00000393962.2 |
ANGPTL4
|
angiopoietin-like 4 |
| chr22_-_43583079 | 8.59 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
| chr9_+_33750515 | 8.53 |
ENST00000361005.5
|
PRSS3
|
protease, serine, 3 |
| chr10_-_75634260 | 8.34 |
ENST00000372765.1
ENST00000351293.3 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr16_+_66638685 | 8.34 |
ENST00000565003.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr19_+_2096868 | 8.24 |
ENST00000395296.1
ENST00000395301.3 |
IZUMO4
|
IZUMO family member 4 |
| chr10_+_11784360 | 8.07 |
ENST00000379215.4
ENST00000420401.1 |
ECHDC3
|
enoyl CoA hydratase domain containing 3 |
| chrX_+_135229731 | 8.06 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
| chr9_+_33750667 | 8.02 |
ENST00000457896.1
ENST00000342836.4 ENST00000429677.3 |
PRSS3
|
protease, serine, 3 |
| chr14_+_94640671 | 8.01 |
ENST00000328839.3
|
PPP4R4
|
protein phosphatase 4, regulatory subunit 4 |
| chr19_-_49015050 | 7.96 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
| chr21_-_44496441 | 7.95 |
ENST00000359624.3
ENST00000352178.5 |
CBS
|
cystathionine-beta-synthase |
| chr2_-_235405679 | 7.89 |
ENST00000390645.2
|
ARL4C
|
ADP-ribosylation factor-like 4C |
| chr19_-_55658281 | 7.82 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr9_+_128509624 | 7.79 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr12_-_47473707 | 7.73 |
ENST00000429635.1
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr1_+_65886326 | 7.68 |
ENST00000371059.3
ENST00000371060.3 ENST00000349533.6 ENST00000406510.3 |
LEPR
|
leptin receptor |
| chr20_+_42295745 | 7.50 |
ENST00000396863.4
ENST00000217026.4 |
MYBL2
|
v-myb avian myeloblastosis viral oncogene homolog-like 2 |
| chr17_-_26903900 | 7.46 |
ENST00000395319.3
ENST00000581807.1 ENST00000584086.1 ENST00000395321.2 |
ALDOC
|
aldolase C, fructose-bisphosphate |
| chr17_+_42081914 | 7.38 |
ENST00000293404.3
ENST00000589767.1 |
NAGS
|
N-acetylglutamate synthase |
| chr12_-_125348329 | 7.36 |
ENST00000546215.1
ENST00000415380.2 ENST00000261693.6 ENST00000376788.1 ENST00000545493.1 |
SCARB1
|
scavenger receptor class B, member 1 |
| chr12_-_125348448 | 7.32 |
ENST00000339570.5
|
SCARB1
|
scavenger receptor class B, member 1 |
| chr19_-_51487282 | 7.29 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
| chr20_+_34203794 | 7.29 |
ENST00000374273.3
|
SPAG4
|
sperm associated antigen 4 |
| chr2_+_173420697 | 7.19 |
ENST00000282077.3
ENST00000392571.2 ENST00000410055.1 |
PDK1
|
pyruvate dehydrogenase kinase, isozyme 1 |
| chr19_+_45843994 | 7.16 |
ENST00000391946.2
|
KLC3
|
kinesin light chain 3 |
| chr16_+_66638567 | 7.15 |
ENST00000567572.1
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr1_+_20915409 | 7.11 |
ENST00000375071.3
|
CDA
|
cytidine deaminase |
| chr16_+_66638616 | 7.08 |
ENST00000564060.1
ENST00000565922.1 |
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3 |
| chr2_+_95691445 | 7.05 |
ENST00000353004.3
ENST00000354078.3 ENST00000349807.3 |
MAL
|
mal, T-cell differentiation protein |
| chr5_-_127873659 | 7.05 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
| chr19_+_41869894 | 7.04 |
ENST00000413014.2
|
TMEM91
|
transmembrane protein 91 |
| chr10_-_75634326 | 7.03 |
ENST00000322635.3
ENST00000444854.2 ENST00000423381.1 ENST00000322680.3 ENST00000394762.2 |
CAMK2G
|
calcium/calmodulin-dependent protein kinase II gamma |
| chr9_-_123639445 | 7.00 |
ENST00000312189.6
|
PHF19
|
PHD finger protein 19 |
| chr19_-_19051103 | 6.99 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr3_-_50336548 | 6.98 |
ENST00000450489.1
ENST00000513170.1 ENST00000450982.1 |
NAT6
HYAL3
|
N-acetyltransferase 6 (GCN5-related) hyaluronoglucosaminidase 3 |
| chr11_+_65686728 | 6.98 |
ENST00000312515.2
ENST00000525501.1 |
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
| chr18_+_56338750 | 6.97 |
ENST00000345724.3
|
MALT1
|
mucosa associated lymphoid tissue lymphoma translocation gene 1 |
| chrX_+_135229600 | 6.95 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
| chr7_+_40174565 | 6.94 |
ENST00000309930.5
ENST00000401647.2 ENST00000335693.4 ENST00000413931.1 ENST00000416370.1 ENST00000540834.1 |
C7orf10
|
succinylCoA:glutarate-CoA transferase |
| chr22_-_41985865 | 6.86 |
ENST00000216259.7
|
PMM1
|
phosphomannomutase 1 |
| chr11_+_65686952 | 6.80 |
ENST00000527119.1
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
| chr11_-_66725837 | 6.78 |
ENST00000393958.2
ENST00000393960.1 ENST00000524491.1 ENST00000355677.3 |
PC
|
pyruvate carboxylase |
| chr2_+_192543153 | 6.70 |
ENST00000425611.2
|
NABP1
|
nucleic acid binding protein 1 |
| chr2_+_70142232 | 6.66 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
| chr12_-_47473642 | 6.61 |
ENST00000266581.4
|
AMIGO2
|
adhesion molecule with Ig-like domain 2 |
| chr19_-_51471381 | 6.61 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
| chr15_+_57884117 | 6.60 |
ENST00000267853.5
|
MYZAP
|
myocardial zonula adherens protein |
| chr18_+_33877654 | 6.57 |
ENST00000257209.4
ENST00000445677.1 ENST00000590592.1 ENST00000359247.4 |
FHOD3
|
formin homology 2 domain containing 3 |
| chr8_-_144655141 | 6.55 |
ENST00000398882.3
|
MROH6
|
maestro heat-like repeat family member 6 |
| chr18_-_28682374 | 6.55 |
ENST00000280904.6
|
DSC2
|
desmocollin 2 |
| chr11_+_65686802 | 6.47 |
ENST00000376991.2
|
DRAP1
|
DR1-associated protein 1 (negative cofactor 2 alpha) |
| chr19_-_14201507 | 6.45 |
ENST00000533683.2
|
SAMD1
|
sterile alpha motif domain containing 1 |
| chr2_+_11886710 | 6.44 |
ENST00000256720.2
ENST00000441684.1 ENST00000423495.1 |
LPIN1
|
lipin 1 |
| chr19_-_1513188 | 6.37 |
ENST00000330475.4
|
ADAMTSL5
|
ADAMTS-like 5 |
| chr17_-_76183111 | 6.34 |
ENST00000405273.1
ENST00000590862.1 ENST00000590430.1 ENST00000586613.1 |
TK1
|
thymidine kinase 1, soluble |
| chr11_-_2158507 | 6.29 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr16_-_87903079 | 6.29 |
ENST00000261622.4
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr9_+_128509663 | 6.29 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
| chr21_-_44495919 | 6.28 |
ENST00000398158.1
|
CBS
|
cystathionine-beta-synthase |
| chr20_-_43280325 | 6.19 |
ENST00000537820.1
|
ADA
|
adenosine deaminase |
| chr3_-_50340996 | 6.17 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
| chr15_+_74833518 | 6.16 |
ENST00000346246.5
|
ARID3B
|
AT rich interactive domain 3B (BRIGHT-like) |
| chr8_+_22457100 | 6.14 |
ENST00000409586.3
|
C8orf58
|
chromosome 8 open reading frame 58 |
| chrX_+_135229559 | 6.13 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
| chr11_-_123065989 | 6.09 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
| chr19_+_45844018 | 6.05 |
ENST00000585434.1
|
KLC3
|
kinesin light chain 3 |
| chr17_+_7942424 | 6.03 |
ENST00000573359.1
|
ALOX15B
|
arachidonate 15-lipoxygenase, type B |
| chr10_+_102106829 | 5.96 |
ENST00000370355.2
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase) |
| chr8_-_23261589 | 5.94 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
| chr22_+_45148432 | 5.93 |
ENST00000389774.2
ENST00000396119.2 ENST00000336963.4 ENST00000356099.6 ENST00000412433.1 |
ARHGAP8
|
Rho GTPase activating protein 8 |
| chr6_+_43739697 | 5.90 |
ENST00000230480.6
|
VEGFA
|
vascular endothelial growth factor A |
| chr20_+_56884752 | 5.88 |
ENST00000244040.3
|
RAB22A
|
RAB22A, member RAS oncogene family |
| chr1_-_143913143 | 5.84 |
ENST00000400889.1
|
FAM72D
|
family with sequence similarity 72, member D |
| chr19_-_55660561 | 5.84 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
| chr15_-_91537723 | 5.83 |
ENST00000394249.3
ENST00000559811.1 ENST00000442656.2 ENST00000557905.1 ENST00000361919.3 |
PRC1
|
protein regulator of cytokinesis 1 |
| chr19_+_48828788 | 5.82 |
ENST00000594198.1
ENST00000597279.1 ENST00000593437.1 |
EMP3
|
epithelial membrane protein 3 |
| chrX_+_64887512 | 5.81 |
ENST00000360270.5
|
MSN
|
moesin |
| chr8_+_28480246 | 5.81 |
ENST00000523149.1
|
EXTL3
|
exostosin-like glycosyltransferase 3 |
| chr7_+_143318020 | 5.81 |
ENST00000444908.2
ENST00000518791.1 ENST00000411497.2 |
FAM115C
|
family with sequence similarity 115, member C |
| chr7_-_102252038 | 5.78 |
ENST00000461209.1
|
RASA4
|
RAS p21 protein activator 4 |
| chr6_-_131384373 | 5.77 |
ENST00000392427.3
ENST00000525271.1 ENST00000527411.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
| chr22_-_30685596 | 5.76 |
ENST00000404953.3
ENST00000407689.3 |
GATSL3
|
GATS protein-like 3 |
| chr2_+_64681103 | 5.76 |
ENST00000464281.1
|
LGALSL
|
lectin, galactoside-binding-like |
| chr7_-_28220354 | 5.75 |
ENST00000283928.5
|
JAZF1
|
JAZF zinc finger 1 |
| chr1_+_206138457 | 5.73 |
ENST00000367128.3
ENST00000431655.2 |
FAM72A
|
family with sequence similarity 72, member A |
| chr21_-_44495964 | 5.72 |
ENST00000398168.1
ENST00000398165.3 |
CBS
|
cystathionine-beta-synthase |
| chr10_+_88718314 | 5.71 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr2_+_24272576 | 5.69 |
ENST00000380986.4
ENST00000452109.1 |
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa |
| chr17_-_58469591 | 5.68 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
| chr19_+_38826477 | 5.64 |
ENST00000409410.2
ENST00000215069.4 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
| chr19_-_51472823 | 5.63 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
| chr19_-_14629224 | 5.63 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
| chr11_-_125366089 | 5.61 |
ENST00000366139.3
ENST00000278919.3 |
FEZ1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr8_+_22457127 | 5.60 |
ENST00000289989.5
|
C8orf58
|
chromosome 8 open reading frame 58 |
| chr7_+_48128816 | 5.59 |
ENST00000395564.4
|
UPP1
|
uridine phosphorylase 1 |
| chr6_+_34204642 | 5.55 |
ENST00000347617.6
ENST00000401473.3 ENST00000311487.5 ENST00000447654.1 ENST00000395004.3 |
HMGA1
|
high mobility group AT-hook 1 |
| chr4_+_75310851 | 5.54 |
ENST00000395748.3
ENST00000264487.2 |
AREG
|
amphiregulin |
| chr9_-_123639600 | 5.49 |
ENST00000373896.3
|
PHF19
|
PHD finger protein 19 |
| chr19_-_15343191 | 5.48 |
ENST00000221730.3
|
EPHX3
|
epoxide hydrolase 3 |
| chr19_-_9929708 | 5.48 |
ENST00000247977.4
ENST00000590277.1 ENST00000588922.1 ENST00000589626.1 ENST00000592067.1 ENST00000586469.1 |
FBXL12
|
F-box and leucine-rich repeat protein 12 |
| chr20_+_62327996 | 5.47 |
ENST00000369996.1
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy |
| chr1_-_153521597 | 5.45 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
| chr6_+_80714318 | 5.45 |
ENST00000369798.2
|
TTK
|
TTK protein kinase |
| chr19_-_19051927 | 5.43 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
| chr19_-_45908292 | 5.43 |
ENST00000360957.5
ENST00000592134.1 |
PPP1R13L
|
protein phosphatase 1, regulatory subunit 13 like |
| chr7_-_4923315 | 5.42 |
ENST00000399583.3
|
RADIL
|
Ras association and DIL domains |
| chr4_-_80994471 | 5.41 |
ENST00000295465.4
|
ANTXR2
|
anthrax toxin receptor 2 |
| chr19_-_19051993 | 5.38 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
| chr7_-_102257139 | 5.36 |
ENST00000521076.1
ENST00000462172.1 ENST00000522801.1 ENST00000449970.2 ENST00000262940.7 |
RASA4
|
RAS p21 protein activator 4 |
| chr19_+_48824711 | 5.33 |
ENST00000599704.1
|
EMP3
|
epithelial membrane protein 3 |
| chr2_+_24272543 | 5.33 |
ENST00000380991.4
|
FKBP1B
|
FK506 binding protein 1B, 12.6 kDa |
| chr20_-_43280361 | 5.26 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
| chr6_+_150263136 | 5.24 |
ENST00000367351.3
|
ULBP2
|
UL16 binding protein 2 |
| chr11_-_12030905 | 5.23 |
ENST00000326932.4
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr20_+_34204939 | 5.23 |
ENST00000454819.1
|
SPAG4
|
sperm associated antigen 4 |
| chr19_+_47104553 | 5.22 |
ENST00000598871.1
ENST00000594523.1 |
CALM3
|
calmodulin 3 (phosphorylase kinase, delta) |
| chr7_-_128049955 | 5.20 |
ENST00000419067.2
ENST00000378717.4 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
| chr19_+_45281118 | 5.17 |
ENST00000270279.3
ENST00000341505.4 |
CBLC
|
Cbl proto-oncogene C, E3 ubiquitin protein ligase |
| chr7_+_43622664 | 5.17 |
ENST00000319357.5
|
STK17A
|
serine/threonine kinase 17a |
| chr8_-_10697281 | 5.16 |
ENST00000524114.1
ENST00000553390.1 ENST00000554914.1 |
PINX1
SOX7
SOX7
|
PIN2/TERF1 interacting, telomerase inhibitor 1 SRY (sex determining region Y)-box 7 Transcription factor SOX-7; Uncharacterized protein; cDNA FLJ58508, highly similar to Transcription factor SOX-7 |
| chr1_+_15736359 | 5.16 |
ENST00000375980.4
|
EFHD2
|
EF-hand domain family, member D2 |
| chr19_-_2096259 | 5.15 |
ENST00000588048.1
ENST00000357066.3 |
MOB3A
|
MOB kinase activator 3A |
| chr1_-_26232522 | 5.15 |
ENST00000399728.1
|
STMN1
|
stathmin 1 |
| chrX_-_153775426 | 5.14 |
ENST00000393562.2
|
G6PD
|
glucose-6-phosphate dehydrogenase |
| chr2_-_9143786 | 5.12 |
ENST00000462696.1
ENST00000305997.3 |
MBOAT2
|
membrane bound O-acyltransferase domain containing 2 |
| chr2_+_64681219 | 5.11 |
ENST00000238875.5
|
LGALSL
|
lectin, galactoside-binding-like |
| chr7_-_102158157 | 5.10 |
ENST00000541662.1
ENST00000306682.6 ENST00000465829.1 |
RASA4B
|
RAS p21 protein activator 4B |
| chr1_-_113498616 | 5.10 |
ENST00000433570.4
ENST00000538576.1 ENST00000458229.1 |
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1 |
| chr20_+_33759854 | 5.08 |
ENST00000216968.4
|
PROCR
|
protein C receptor, endothelial |
| chr1_+_45265897 | 5.07 |
ENST00000372201.4
|
PLK3
|
polo-like kinase 3 |
| chr20_+_25228669 | 5.01 |
ENST00000216962.4
|
PYGB
|
phosphorylase, glycogen; brain |
| chr7_-_4923259 | 4.98 |
ENST00000536091.1
|
RADIL
|
Ras association and DIL domains |
| chr10_-_134145321 | 4.96 |
ENST00000368625.4
ENST00000368619.3 ENST00000456004.1 ENST00000368620.2 |
STK32C
|
serine/threonine kinase 32C |
| chr11_-_2160611 | 4.96 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
| chr19_-_51845378 | 4.95 |
ENST00000335624.4
|
VSIG10L
|
V-set and immunoglobulin domain containing 10 like |
| chr10_+_112257596 | 4.95 |
ENST00000369583.3
|
DUSP5
|
dual specificity phosphatase 5 |
| chr22_-_20255212 | 4.93 |
ENST00000416372.1
|
RTN4R
|
reticulon 4 receptor |
| chr2_+_48541776 | 4.93 |
ENST00000413569.1
ENST00000340553.3 |
FOXN2
|
forkhead box N2 |
| chr12_+_53491220 | 4.91 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
| chr13_-_23949671 | 4.91 |
ENST00000402364.1
|
SACS
|
spastic ataxia of Charlevoix-Saguenay (sacsin) |
| chr10_-_135090360 | 4.90 |
ENST00000486609.1
ENST00000445355.3 ENST00000485491.2 |
ADAM8
|
ADAM metallopeptidase domain 8 |
| chr11_-_12030629 | 4.90 |
ENST00000396505.2
|
DKK3
|
dickkopf WNT signaling pathway inhibitor 3 |
| chr17_+_79989937 | 4.90 |
ENST00000580965.1
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) |
| chr10_-_135090338 | 4.89 |
ENST00000415217.3
|
ADAM8
|
ADAM metallopeptidase domain 8 |
| chr2_-_26205340 | 4.88 |
ENST00000264712.3
|
KIF3C
|
kinesin family member 3C |
| chr17_-_41623259 | 4.88 |
ENST00000538265.1
ENST00000591713.1 |
ETV4
|
ets variant 4 |
| chr2_+_241392227 | 4.85 |
ENST00000420138.1
|
GPC1
|
glypican 1 |
| chr4_+_2794750 | 4.85 |
ENST00000452765.2
ENST00000389838.2 |
SH3BP2
|
SH3-domain binding protein 2 |
| chr22_+_44319619 | 4.84 |
ENST00000216180.3
|
PNPLA3
|
patatin-like phospholipase domain containing 3 |
| chr22_+_40390930 | 4.83 |
ENST00000333407.6
|
FAM83F
|
family with sequence similarity 83, member F |
| chr22_+_30792846 | 4.82 |
ENST00000312932.9
ENST00000428195.1 |
SEC14L2
|
SEC14-like 2 (S. cerevisiae) |
| chr8_+_26371763 | 4.82 |
ENST00000521913.1
|
DPYSL2
|
dihydropyrimidinase-like 2 |
| chr19_+_30302805 | 4.81 |
ENST00000262643.3
ENST00000575243.1 ENST00000357943.5 |
CCNE1
|
cyclin E1 |
| chr10_+_88718397 | 4.81 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
| chr19_+_917287 | 4.77 |
ENST00000592648.1
ENST00000234371.5 |
KISS1R
|
KISS1 receptor |
| chr7_-_128050027 | 4.77 |
ENST00000343214.4
ENST00000354269.5 ENST00000348127.6 ENST00000497868.1 |
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1 |
| chr1_+_28199047 | 4.76 |
ENST00000373925.1
ENST00000328928.7 ENST00000373927.3 ENST00000427466.1 ENST00000442118.1 ENST00000373921.3 |
THEMIS2
|
thymocyte selection associated family member 2 |
Network of associatons between targets according to the STRING database.
First level regulatory network of PATZ1_KLF4
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 8.7 | 26.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 8.1 | 24.2 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
| 7.7 | 46.2 | GO:0002803 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 6.7 | 20.0 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 5.8 | 5.8 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
| 4.9 | 14.7 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 4.6 | 4.6 | GO:1900756 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 4.2 | 8.5 | GO:0009620 | response to fungus(GO:0009620) |
| 4.2 | 12.7 | GO:0042938 | dipeptide transport(GO:0042938) |
| 3.8 | 11.5 | GO:0046103 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 3.8 | 11.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
| 3.8 | 34.0 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 3.7 | 11.0 | GO:0035419 | activation of MAPK activity involved in innate immune response(GO:0035419) |
| 3.6 | 14.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
| 3.5 | 13.9 | GO:0006218 | uridine catabolic process(GO:0006218) |
| 3.4 | 3.4 | GO:1905232 | cellular response to L-glutamate(GO:1905232) |
| 3.3 | 3.3 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
| 3.2 | 9.5 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
| 3.0 | 9.1 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 2.9 | 2.9 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 2.7 | 21.7 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 2.7 | 16.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 2.7 | 2.7 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
| 2.6 | 10.5 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
| 2.6 | 7.9 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 2.6 | 10.4 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 2.6 | 2.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
| 2.5 | 7.6 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
| 2.5 | 2.5 | GO:0003169 | coronary vein morphogenesis(GO:0003169) |
| 2.4 | 9.7 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 2.4 | 2.4 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 2.3 | 9.4 | GO:1902613 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
| 2.3 | 2.3 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 2.3 | 18.4 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 2.3 | 6.9 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 2.3 | 6.8 | GO:0044771 | meiotic cell cycle phase transition(GO:0044771) regulation of meiotic cell cycle phase transition(GO:1901993) negative regulation of meiotic cell cycle phase transition(GO:1901994) |
| 2.3 | 6.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
| 2.2 | 6.7 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
| 2.2 | 6.7 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
| 2.2 | 19.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 2.2 | 6.6 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 2.2 | 11.0 | GO:0090402 | oncogene-induced cell senescence(GO:0090402) |
| 2.2 | 17.5 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 2.2 | 17.3 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
| 2.2 | 10.8 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 2.2 | 2.2 | GO:0015917 | aminophospholipid transport(GO:0015917) |
| 2.1 | 6.4 | GO:1902534 | single-organism membrane invagination(GO:1902534) |
| 2.1 | 8.4 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 2.1 | 4.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
| 2.1 | 16.8 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 2.1 | 12.5 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 2.1 | 10.4 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
| 2.1 | 4.2 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
| 2.1 | 8.2 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 2.0 | 6.1 | GO:1904170 | regulation of bleb assembly(GO:1904170) positive regulation of bleb assembly(GO:1904172) |
| 2.0 | 24.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
| 2.0 | 12.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 2.0 | 14.0 | GO:0035900 | response to isolation stress(GO:0035900) |
| 2.0 | 12.0 | GO:0051643 | endoplasmic reticulum localization(GO:0051643) |
| 2.0 | 43.5 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 2.0 | 5.9 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 2.0 | 2.0 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
| 2.0 | 5.9 | GO:1904351 | negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
| 1.9 | 5.8 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
| 1.9 | 1.9 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 1.9 | 7.8 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
| 1.9 | 1.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.9 | 5.8 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
| 1.9 | 3.8 | GO:0015798 | myo-inositol transport(GO:0015798) |
| 1.9 | 7.6 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.9 | 11.4 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
| 1.9 | 5.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 1.9 | 5.6 | GO:0002934 | desmosome organization(GO:0002934) |
| 1.9 | 5.6 | GO:2001035 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
| 1.9 | 48.2 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 1.8 | 5.5 | GO:0021558 | trochlear nerve development(GO:0021558) |
| 1.8 | 9.2 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
| 1.8 | 9.1 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 1.8 | 5.4 | GO:0021897 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
| 1.8 | 9.0 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 1.8 | 5.4 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
| 1.8 | 5.4 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
| 1.8 | 3.6 | GO:1902724 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
| 1.8 | 5.3 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
| 1.8 | 5.3 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
| 1.8 | 12.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 1.7 | 6.9 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
| 1.7 | 5.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.7 | 3.4 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
| 1.7 | 1.7 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
| 1.7 | 5.0 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 1.7 | 5.0 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
| 1.7 | 6.7 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 1.7 | 1.7 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 1.7 | 6.6 | GO:0070981 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 1.7 | 10.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 1.7 | 26.5 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 1.7 | 5.0 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
| 1.6 | 6.6 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
| 1.6 | 8.1 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 1.6 | 3.2 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 1.6 | 3.2 | GO:0002159 | desmosome assembly(GO:0002159) |
| 1.6 | 4.8 | GO:0051300 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
| 1.6 | 9.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
| 1.6 | 6.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
| 1.6 | 9.6 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 1.6 | 8.0 | GO:0070384 | Harderian gland development(GO:0070384) |
| 1.6 | 46.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.6 | 1.6 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 1.6 | 3.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
| 1.6 | 4.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 1.5 | 3.1 | GO:0009408 | response to heat(GO:0009408) |
| 1.5 | 3.1 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
| 1.5 | 17.0 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 1.5 | 4.6 | GO:1903609 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
| 1.5 | 4.6 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
| 1.5 | 19.9 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
| 1.5 | 7.6 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 1.5 | 12.2 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
| 1.5 | 7.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.5 | 1.5 | GO:0002585 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 1.5 | 4.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 1.5 | 1.5 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
| 1.5 | 14.7 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 1.5 | 7.3 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
| 1.5 | 5.9 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 1.5 | 5.8 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
| 1.5 | 8.7 | GO:0006642 | triglyceride mobilization(GO:0006642) |
| 1.5 | 2.9 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 1.5 | 8.7 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 1.4 | 2.9 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
| 1.4 | 2.9 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 1.4 | 14.4 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 1.4 | 2.9 | GO:0010165 | response to X-ray(GO:0010165) |
| 1.4 | 5.7 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 1.4 | 18.5 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 1.4 | 2.9 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
| 1.4 | 4.3 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 1.4 | 9.9 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 1.4 | 15.5 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 1.4 | 7.0 | GO:0030035 | microspike assembly(GO:0030035) |
| 1.4 | 4.2 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 1.4 | 7.0 | GO:0061143 | alveolar primary septum development(GO:0061143) |
| 1.4 | 4.2 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 1.4 | 4.2 | GO:0046947 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 1.4 | 1.4 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
| 1.4 | 4.1 | GO:0048627 | myoblast development(GO:0048627) |
| 1.4 | 4.1 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 1.4 | 6.8 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
| 1.4 | 1.4 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) retrograde trans-synaptic signaling by soluble gas(GO:0098923) trans-synaptic signaling by soluble gas(GO:0099543) |
| 1.4 | 1.4 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 1.3 | 5.4 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 1.3 | 13.4 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 1.3 | 1.3 | GO:1900195 | positive regulation of oocyte maturation(GO:1900195) |
| 1.3 | 19.9 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 1.3 | 10.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 1.3 | 1.3 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 1.3 | 30.3 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 1.3 | 5.3 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 1.3 | 1.3 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
| 1.3 | 7.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
| 1.3 | 6.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
| 1.3 | 2.6 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.3 | 5.1 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 1.3 | 9.0 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
| 1.3 | 3.8 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 1.3 | 3.8 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
| 1.3 | 6.4 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 1.3 | 5.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 1.3 | 13.9 | GO:0048102 | autophagic cell death(GO:0048102) |
| 1.3 | 5.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 1.3 | 3.8 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 1.3 | 3.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.3 | 7.5 | GO:0051012 | microtubule sliding(GO:0051012) |
| 1.2 | 16.2 | GO:0051639 | actin filament network formation(GO:0051639) |
| 1.2 | 5.0 | GO:0044752 | response to human chorionic gonadotropin(GO:0044752) |
| 1.2 | 9.9 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 1.2 | 3.7 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 1.2 | 6.2 | GO:0036414 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 1.2 | 6.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 1.2 | 6.2 | GO:1990928 | response to amino acid starvation(GO:1990928) |
| 1.2 | 1.2 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 1.2 | 14.8 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
| 1.2 | 27.0 | GO:0032060 | bleb assembly(GO:0032060) |
| 1.2 | 3.7 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.2 | 1.2 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 1.2 | 3.6 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
| 1.2 | 3.6 | GO:0050894 | determination of affect(GO:0050894) |
| 1.2 | 30.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 1.2 | 16.9 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 1.2 | 3.6 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
| 1.2 | 1.2 | GO:1902954 | regulation of early endosome to recycling endosome transport(GO:1902954) |
| 1.2 | 1.2 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 1.2 | 3.6 | GO:1904482 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
| 1.2 | 7.1 | GO:0071476 | cellular hypotonic response(GO:0071476) |
| 1.2 | 13.1 | GO:0010994 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
| 1.2 | 2.4 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
| 1.2 | 4.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 1.2 | 5.9 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 1.2 | 4.7 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 1.2 | 5.9 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
| 1.2 | 10.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 1.2 | 1.2 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
| 1.1 | 5.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
| 1.1 | 4.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 1.1 | 3.4 | GO:0060613 | fat pad development(GO:0060613) |
| 1.1 | 1.1 | GO:0071373 | cellular response to luteinizing hormone stimulus(GO:0071373) |
| 1.1 | 4.5 | GO:0035425 | autocrine signaling(GO:0035425) |
| 1.1 | 3.4 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 1.1 | 3.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
| 1.1 | 2.2 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
| 1.1 | 5.6 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
| 1.1 | 3.3 | GO:0086098 | angiotensin-activated signaling pathway involved in heart process(GO:0086098) |
| 1.1 | 10.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 1.1 | 4.5 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 1.1 | 14.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 1.1 | 3.3 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
| 1.1 | 13.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 1.1 | 1.1 | GO:1901079 | positive regulation of relaxation of muscle(GO:1901079) |
| 1.1 | 1.1 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 1.1 | 10.8 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
| 1.1 | 6.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
| 1.1 | 1.1 | GO:0097191 | extrinsic apoptotic signaling pathway(GO:0097191) |
| 1.1 | 4.2 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 1.1 | 7.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.1 | 1.1 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 1.0 | 3.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 1.0 | 7.3 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
| 1.0 | 4.2 | GO:0090135 | actin filament branching(GO:0090135) |
| 1.0 | 1.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
| 1.0 | 7.2 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 1.0 | 8.3 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.0 | 2.1 | GO:0070836 | caveola assembly(GO:0070836) |
| 1.0 | 9.2 | GO:0046618 | drug export(GO:0046618) |
| 1.0 | 6.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
| 1.0 | 4.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.0 | 8.2 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 1.0 | 6.1 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
| 1.0 | 6.1 | GO:0007296 | vitellogenesis(GO:0007296) |
| 1.0 | 6.1 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 1.0 | 2.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
| 1.0 | 4.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 1.0 | 1.0 | GO:0010644 | cell communication by electrical coupling(GO:0010644) |
| 1.0 | 3.0 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 1.0 | 3.0 | GO:0035565 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
| 1.0 | 3.0 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
| 1.0 | 16.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 1.0 | 3.0 | GO:0042418 | epinephrine biosynthetic process(GO:0042418) |
| 1.0 | 1.9 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 1.0 | 5.8 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 1.0 | 1.0 | GO:0021860 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
| 1.0 | 6.8 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
| 1.0 | 15.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 1.0 | 25.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 1.0 | 1.0 | GO:0043585 | nose morphogenesis(GO:0043585) |
| 1.0 | 3.8 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 1.0 | 4.8 | GO:0007068 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
| 1.0 | 2.9 | GO:0043315 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 0.9 | 2.8 | GO:0019860 | uracil metabolic process(GO:0019860) |
| 0.9 | 4.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
| 0.9 | 2.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.9 | 1.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.9 | 2.8 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.9 | 0.9 | GO:0060722 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.9 | 13.0 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
| 0.9 | 9.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.9 | 2.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.9 | 3.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.9 | 25.7 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.9 | 2.7 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
| 0.9 | 1.8 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.9 | 9.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.9 | 7.3 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
| 0.9 | 4.5 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.9 | 4.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.9 | 1.8 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.9 | 2.7 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.9 | 3.6 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.9 | 2.7 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.9 | 2.7 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
| 0.9 | 1.8 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.9 | 1.8 | GO:1901656 | glycoside transport(GO:1901656) |
| 0.9 | 2.7 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
| 0.9 | 3.5 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.9 | 6.2 | GO:0006868 | glutamine transport(GO:0006868) |
| 0.9 | 1.8 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 0.9 | 2.6 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.9 | 2.6 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.9 | 3.5 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
| 0.9 | 5.2 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.9 | 3.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
| 0.9 | 2.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
| 0.9 | 2.6 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.9 | 2.6 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
| 0.9 | 6.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.8 | 5.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.8 | 1.7 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.8 | 2.5 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 0.8 | 2.5 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.8 | 8.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 0.8 | 3.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.8 | 13.4 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.8 | 11.7 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.8 | 2.5 | GO:0021722 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
| 0.8 | 5.0 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
| 0.8 | 2.5 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.8 | 0.8 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) positive regulation of oxidative stress-induced neuron death(GO:1903223) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.8 | 1.6 | GO:0030497 | fatty acid elongation(GO:0030497) |
| 0.8 | 0.8 | GO:1903438 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.8 | 3.3 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.8 | 4.1 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.8 | 3.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.8 | 2.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.8 | 7.3 | GO:0036010 | protein localization to endosome(GO:0036010) |
| 0.8 | 2.4 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
| 0.8 | 4.8 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.8 | 3.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.8 | 6.4 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 0.8 | 5.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.8 | 8.8 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.8 | 3.2 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
| 0.8 | 2.4 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.8 | 1.6 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.8 | 0.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
| 0.8 | 7.9 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.8 | 2.4 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.8 | 7.9 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.8 | 9.4 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.8 | 0.8 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.8 | 2.3 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
| 0.8 | 2.3 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.8 | 3.9 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 0.8 | 3.1 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.8 | 2.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.8 | 3.1 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.8 | 2.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
| 0.8 | 5.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
| 0.8 | 3.9 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
| 0.8 | 3.1 | GO:0019541 | acetate biosynthetic process(GO:0019413) acetyl-CoA biosynthetic process from acetate(GO:0019427) propionate metabolic process(GO:0019541) propionate biosynthetic process(GO:0019542) |
| 0.8 | 0.8 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
| 0.8 | 0.8 | GO:1904582 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
| 0.8 | 1.5 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.8 | 3.8 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
| 0.8 | 0.8 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
| 0.8 | 3.0 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.8 | 0.8 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 0.8 | 1.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 0.8 | 0.8 | GO:0003275 | apoptotic process involved in outflow tract morphogenesis(GO:0003275) regulation of apoptotic process involved in outflow tract morphogenesis(GO:1902256) |
| 0.7 | 3.0 | GO:0021564 | vagus nerve development(GO:0021564) |
| 0.7 | 0.7 | GO:0006971 | hypotonic response(GO:0006971) |
| 0.7 | 1.5 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.7 | 3.7 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.7 | 2.2 | GO:0019417 | sulfur oxidation(GO:0019417) |
| 0.7 | 32.7 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.7 | 4.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.7 | 0.7 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 0.7 | 11.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
| 0.7 | 5.9 | GO:0051798 | positive regulation of hair follicle development(GO:0051798) |
| 0.7 | 5.1 | GO:0010820 | positive regulation of T cell chemotaxis(GO:0010820) |
| 0.7 | 2.9 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
| 0.7 | 2.9 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.7 | 2.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.7 | 1.4 | GO:0033625 | positive regulation of integrin activation(GO:0033625) |
| 0.7 | 2.9 | GO:0070141 | response to UV-A(GO:0070141) |
| 0.7 | 4.3 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
| 0.7 | 7.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.7 | 5.0 | GO:0021842 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
| 0.7 | 15.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
| 0.7 | 4.3 | GO:0031335 | regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.7 | 4.3 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.7 | 1.4 | GO:0070859 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
| 0.7 | 2.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 | 2.1 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
| 0.7 | 3.5 | GO:0030047 | actin modification(GO:0030047) |
| 0.7 | 1.4 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
| 0.7 | 0.7 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
| 0.7 | 3.5 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
| 0.7 | 2.1 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.7 | 1.4 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
| 0.7 | 2.8 | GO:1904448 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.7 | 1.4 | GO:0045013 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.7 | 1.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.7 | 15.2 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.7 | 0.7 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) negative regulation of T-helper 1 cell differentiation(GO:0045626) |
| 0.7 | 0.7 | GO:0008355 | olfactory learning(GO:0008355) |
| 0.7 | 3.4 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
| 0.7 | 2.0 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.7 | 5.4 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.7 | 10.8 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.7 | 0.7 | GO:0021854 | hypothalamus development(GO:0021854) |
| 0.7 | 2.7 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.7 | 0.7 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.7 | 1.3 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.7 | 8.7 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
| 0.7 | 4.0 | GO:0099639 | neurotransmitter receptor transport, endosome to plasma membrane(GO:0099639) |
| 0.7 | 1.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.7 | 3.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
| 0.7 | 0.7 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.7 | 4.7 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.7 | 5.3 | GO:0046078 | dUMP metabolic process(GO:0046078) |
| 0.7 | 2.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) |
| 0.7 | 3.3 | GO:1904222 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.7 | 4.6 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.6 | 7.1 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.6 | 0.6 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
| 0.6 | 3.2 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.6 | 0.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
| 0.6 | 1.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.6 | 9.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.6 | 3.9 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.6 | 2.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.6 | 7.7 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.6 | 1.9 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.6 | 5.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 0.6 | 4.5 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.6 | 4.5 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
| 0.6 | 1.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.6 | 3.8 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
| 0.6 | 5.1 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.6 | 0.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.6 | 1.9 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.6 | 3.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
| 0.6 | 0.6 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.6 | 2.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.6 | 8.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.6 | 0.6 | GO:0019249 | lactate biosynthetic process(GO:0019249) |
| 0.6 | 1.9 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.6 | 1.9 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.6 | 3.1 | GO:1903412 | response to bile acid(GO:1903412) |
| 0.6 | 4.4 | GO:0043622 | cortical microtubule organization(GO:0043622) |
| 0.6 | 1.9 | GO:0072185 | metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) |
| 0.6 | 5.0 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
| 0.6 | 8.7 | GO:0015816 | glycine transport(GO:0015816) |
| 0.6 | 1.9 | GO:0007538 | primary sex determination(GO:0007538) |
| 0.6 | 6.8 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
| 0.6 | 1.9 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
| 0.6 | 3.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.6 | 4.3 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
| 0.6 | 30.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
| 0.6 | 2.5 | GO:0071484 | cellular response to light intensity(GO:0071484) |
| 0.6 | 0.6 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
| 0.6 | 0.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.6 | 3.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.6 | 1.2 | GO:0050807 | regulation of synapse organization(GO:0050807) |
| 0.6 | 4.3 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
| 0.6 | 1.8 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
| 0.6 | 0.6 | GO:1900244 | positive regulation of synaptic vesicle endocytosis(GO:1900244) positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.6 | 4.3 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.6 | 2.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.6 | 0.6 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.6 | 2.4 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.6 | 6.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
| 0.6 | 1.2 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
| 0.6 | 2.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.6 | 2.4 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.6 | 0.6 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.6 | 0.6 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
| 0.6 | 0.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
| 0.6 | 2.4 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
| 0.6 | 0.6 | GO:0006565 | L-serine catabolic process(GO:0006565) |
| 0.6 | 4.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
| 0.6 | 1.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.6 | 4.2 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.6 | 1.8 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 | 1.2 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
| 0.6 | 2.4 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.6 | 1.8 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.6 | 7.7 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.6 | 1.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
| 0.6 | 1.7 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.6 | 2.3 | GO:2000490 | negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.6 | 2.9 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
| 0.6 | 1.7 | GO:1903697 | negative regulation of microvillus assembly(GO:1903697) |
| 0.6 | 0.6 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
| 0.6 | 0.6 | GO:1901078 | negative regulation of relaxation of muscle(GO:1901078) |
| 0.6 | 0.6 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
| 0.6 | 12.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.6 | 1.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.6 | 0.6 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.6 | 11.5 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
| 0.6 | 5.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
| 0.6 | 1.1 | GO:0042109 | lymphotoxin A production(GO:0032641) lymphotoxin A biosynthetic process(GO:0042109) |
| 0.6 | 3.4 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.6 | 6.2 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.6 | 0.6 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.6 | 4.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.6 | 1.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.6 | 1.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.6 | 1.7 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.6 | 5.6 | GO:0043320 | natural killer cell degranulation(GO:0043320) |
| 0.6 | 1.1 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.6 | 3.4 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.6 | 1.7 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.6 | 1.7 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
| 0.6 | 3.4 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.6 | 1.7 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.6 | 2.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
| 0.6 | 3.3 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.6 | 4.5 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
| 0.6 | 2.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.6 | 0.6 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.6 | 3.3 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
| 0.6 | 1.7 | GO:0070142 | synaptic vesicle budding(GO:0070142) |
| 0.6 | 4.4 | GO:0046836 | glycolipid transport(GO:0046836) |
| 0.6 | 1.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.6 | 2.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.6 | 2.2 | GO:0021559 | trigeminal nerve development(GO:0021559) |
| 0.6 | 1.1 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
| 0.5 | 2.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 0.5 | 7.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.5 | 8.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.5 | 2.7 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
| 0.5 | 2.7 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.5 | 3.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.5 | 15.7 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
| 0.5 | 2.2 | GO:0007343 | egg activation(GO:0007343) |
| 0.5 | 6.5 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.5 | 1.1 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.5 | 3.2 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.5 | 0.5 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
| 0.5 | 2.7 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
| 0.5 | 2.1 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.5 | 9.1 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.5 | 5.8 | GO:0006907 | pinocytosis(GO:0006907) |
| 0.5 | 1.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
| 0.5 | 3.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.5 | 1.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
| 0.5 | 2.1 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 0.5 | 1.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
| 0.5 | 3.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
| 0.5 | 3.7 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
| 0.5 | 5.8 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
| 0.5 | 1.0 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.5 | 5.2 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.5 | 7.8 | GO:0010528 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.5 | 2.1 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
| 0.5 | 1.5 | GO:0021503 | neural fold bending(GO:0021503) |
| 0.5 | 2.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
| 0.5 | 3.6 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.5 | 2.6 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
| 0.5 | 0.5 | GO:0060061 | Spemann organizer formation(GO:0060061) |
| 0.5 | 3.6 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
| 0.5 | 6.6 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.5 | 1.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.5 | 1.0 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
| 0.5 | 2.0 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.5 | 1.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 0.5 | 9.6 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
| 0.5 | 17.1 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) glycolytic process through glucose-6-phosphate(GO:0061620) |
| 0.5 | 2.0 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
| 0.5 | 5.5 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
| 0.5 | 1.5 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.5 | 2.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.5 | 7.5 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.5 | 6.0 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.5 | 2.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.5 | 1.0 | GO:1900273 | positive regulation of long-term synaptic potentiation(GO:1900273) |
| 0.5 | 0.5 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
| 0.5 | 0.5 | GO:0007521 | muscle cell fate determination(GO:0007521) |
| 0.5 | 2.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.5 | 25.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.5 | 2.0 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.5 | 2.4 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
| 0.5 | 5.4 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.5 | 2.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.5 | 7.3 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.5 | 10.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.5 | 5.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.5 | 2.9 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.5 | 2.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.5 | 1.9 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 0.5 | 7.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.5 | 0.5 | GO:0034694 | response to prostaglandin(GO:0034694) |
| 0.5 | 5.3 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.5 | 2.9 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
| 0.5 | 0.5 | GO:0002543 | activation of blood coagulation via clotting cascade(GO:0002543) |
| 0.5 | 23.9 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.5 | 2.9 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
| 0.5 | 1.9 | GO:0003335 | corneocyte development(GO:0003335) |
| 0.5 | 4.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.5 | 1.4 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.5 | 2.8 | GO:0003383 | apical constriction(GO:0003383) |
| 0.5 | 5.2 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
| 0.5 | 3.8 | GO:0015074 | DNA integration(GO:0015074) |
| 0.5 | 5.2 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
| 0.5 | 0.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.5 | 0.9 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 0.5 | 0.5 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
| 0.5 | 2.3 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
| 0.5 | 2.8 | GO:0042335 | cuticle development(GO:0042335) |
| 0.5 | 1.9 | GO:0042851 | L-alanine metabolic process(GO:0042851) L-alanine catabolic process(GO:0042853) |
| 0.5 | 0.5 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
| 0.5 | 1.4 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.5 | 0.5 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.5 | 6.5 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.5 | 21.7 | GO:1901998 | toxin transport(GO:1901998) |
| 0.5 | 3.7 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.5 | 2.3 | GO:0044571 | [2Fe-2S] cluster assembly(GO:0044571) |
| 0.5 | 0.5 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
| 0.5 | 3.7 | GO:0035385 | Roundabout signaling pathway(GO:0035385) |
| 0.5 | 0.9 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.5 | 0.9 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
| 0.5 | 0.9 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.5 | 3.6 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
| 0.5 | 0.5 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.5 | 1.4 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 0.5 | 1.4 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
| 0.5 | 7.7 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
| 0.5 | 3.6 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.5 | 4.1 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
| 0.5 | 2.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.5 | 0.5 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
| 0.4 | 1.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.4 | 1.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
| 0.4 | 2.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.4 | 1.8 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.4 | 5.3 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.4 | 0.4 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.4 | 2.7 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.4 | 2.7 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.4 | 5.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.4 | 1.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.4 | 2.2 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.4 | 1.8 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.4 | 3.5 | GO:0090009 | primitive streak formation(GO:0090009) |
| 0.4 | 2.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.4 | 0.4 | GO:0036446 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.4 | 14.8 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
| 0.4 | 1.3 | GO:0071048 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.4 | 1.3 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 0.4 | 2.2 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.4 | 7.3 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.4 | 0.9 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
| 0.4 | 0.4 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.4 | 1.3 | GO:0035493 | SNARE complex assembly(GO:0035493) |
| 0.4 | 0.4 | GO:0046108 | uridine metabolic process(GO:0046108) |
| 0.4 | 0.4 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
| 0.4 | 3.4 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
| 0.4 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.4 | 2.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.4 | 2.1 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.4 | 0.8 | GO:0071727 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
| 0.4 | 9.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.4 | 5.8 | GO:0016242 | negative regulation of macroautophagy(GO:0016242) |
| 0.4 | 1.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.4 | 0.8 | GO:0060319 | primitive erythrocyte differentiation(GO:0060319) |
| 0.4 | 0.4 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
| 0.4 | 4.2 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
| 0.4 | 1.2 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 0.4 | 4.6 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.4 | 0.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.4 | 1.2 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 0.4 | 1.6 | GO:0010269 | response to selenium ion(GO:0010269) |
| 0.4 | 5.4 | GO:0033622 | integrin activation(GO:0033622) |
| 0.4 | 9.0 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
| 0.4 | 0.8 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.4 | 1.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 | 2.5 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.4 | 1.6 | GO:1904647 | response to rotenone(GO:1904647) |
| 0.4 | 1.6 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
| 0.4 | 0.8 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
| 0.4 | 1.6 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
| 0.4 | 0.8 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.4 | 0.8 | GO:0070055 | mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.4 | 0.4 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
| 0.4 | 0.4 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
| 0.4 | 1.2 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.4 | 2.4 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
| 0.4 | 0.8 | GO:0010728 | regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.4 | 2.0 | GO:0014028 | notochord formation(GO:0014028) |
| 0.4 | 4.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.4 | 2.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.4 | 0.8 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
| 0.4 | 0.4 | GO:2000170 | positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.4 | 1.2 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.4 | 5.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.4 | 0.4 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
| 0.4 | 2.0 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.4 | 1.2 | GO:0060872 | semicircular canal development(GO:0060872) |
| 0.4 | 1.6 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
| 0.4 | 4.4 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.4 | 0.4 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
| 0.4 | 17.0 | GO:0042339 | keratan sulfate metabolic process(GO:0042339) |
| 0.4 | 3.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.4 | 2.8 | GO:0070673 | response to interleukin-18(GO:0070673) |
| 0.4 | 1.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
| 0.4 | 4.3 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.4 | 2.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.4 | 2.0 | GO:0043606 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
| 0.4 | 0.4 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
| 0.4 | 2.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 0.4 | 2.0 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.4 | 1.2 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 0.4 | 1.6 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
| 0.4 | 0.8 | GO:0014848 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.4 | 1.2 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.4 | 1.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
| 0.4 | 0.4 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) |
| 0.4 | 0.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
| 0.4 | 0.8 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.4 | 4.2 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 0.4 | 2.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
| 0.4 | 3.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.4 | 5.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.4 | 1.2 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.4 | 1.9 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 0.4 | 0.4 | GO:0010543 | regulation of platelet activation(GO:0010543) |
| 0.4 | 41.0 | GO:0070268 | cornification(GO:0070268) |
| 0.4 | 0.8 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.4 | 0.8 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
| 0.4 | 1.9 | GO:0002666 | positive regulation of T cell tolerance induction(GO:0002666) |
| 0.4 | 0.8 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.4 | 1.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.4 | 2.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
| 0.4 | 0.8 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 0.4 | 0.8 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
| 0.4 | 1.1 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.4 | 0.4 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
| 0.4 | 5.2 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.4 | 0.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.4 | 2.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.4 | 1.5 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.4 | 0.7 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.4 | 0.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
| 0.4 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.4 | 1.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
| 0.4 | 10.7 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.4 | 3.7 | GO:1900084 | regulation of peptidyl-tyrosine autophosphorylation(GO:1900084) |
| 0.4 | 1.8 | GO:0015862 | uridine transport(GO:0015862) |
| 0.4 | 0.4 | GO:0072114 | pronephros morphogenesis(GO:0072114) |
| 0.4 | 5.9 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
| 0.4 | 1.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.4 | 0.7 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.4 | 1.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.4 | 13.2 | GO:1902850 | microtubule cytoskeleton organization involved in mitosis(GO:1902850) |
| 0.4 | 12.1 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.4 | 2.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.4 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.4 | 2.2 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
| 0.4 | 0.7 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
| 0.4 | 2.2 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.4 | 3.6 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
| 0.4 | 2.9 | GO:0001845 | phagolysosome assembly(GO:0001845) |
| 0.4 | 2.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
| 0.4 | 1.8 | GO:0072221 | distal convoluted tubule development(GO:0072025) metanephric distal convoluted tubule development(GO:0072221) |
| 0.4 | 1.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
| 0.4 | 0.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.4 | 0.4 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.4 | 2.5 | GO:0071806 | protein transmembrane transport(GO:0071806) |
| 0.4 | 2.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.4 | 15.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
| 0.4 | 1.8 | GO:0035063 | nuclear speck organization(GO:0035063) |
| 0.4 | 4.6 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.4 | 0.4 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 0.4 | 3.9 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.3 | 1.7 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
| 0.3 | 0.3 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
| 0.3 | 2.1 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.3 | 1.0 | GO:0035313 | wound healing, spreading of epidermal cells(GO:0035313) |
| 0.3 | 1.0 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
| 0.3 | 9.4 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
| 0.3 | 6.3 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.3 | 1.0 | GO:0060073 | micturition(GO:0060073) |
| 0.3 | 1.4 | GO:0030728 | ovulation(GO:0030728) |
| 0.3 | 17.2 | GO:0008088 | axo-dendritic transport(GO:0008088) |
| 0.3 | 3.1 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.3 | 0.3 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.3 | 2.4 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 | 0.3 | GO:0021631 | optic nerve morphogenesis(GO:0021631) optic nerve structural organization(GO:0021633) |
| 0.3 | 0.7 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.3 | 0.3 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
| 0.3 | 2.0 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
| 0.3 | 0.3 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
| 0.3 | 1.7 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) |
| 0.3 | 2.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
| 0.3 | 1.4 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
| 0.3 | 1.0 | GO:0048749 | compound eye development(GO:0048749) |
| 0.3 | 0.3 | GO:0060841 | venous blood vessel development(GO:0060841) |
| 0.3 | 1.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.3 | 1.3 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
| 0.3 | 0.7 | GO:0032196 | transposition(GO:0032196) |
| 0.3 | 0.7 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
| 0.3 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.3 | 8.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.3 | 1.7 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.3 | 1.0 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.3 | 0.7 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
| 0.3 | 4.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 1.3 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.3 | 0.3 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
| 0.3 | 2.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
| 0.3 | 1.0 | GO:0032103 | positive regulation of response to external stimulus(GO:0032103) |
| 0.3 | 0.7 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
| 0.3 | 2.3 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 1.7 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
| 0.3 | 0.7 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.3 | 1.6 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
| 0.3 | 1.3 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 0.3 | 1.3 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 0.3 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
| 0.3 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
| 0.3 | 2.3 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.3 | 3.9 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.3 | 1.6 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
| 0.3 | 0.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.3 | 2.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.3 | 0.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 0.3 | 1.0 | GO:1904597 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
| 0.3 | 8.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.3 | 0.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.3 | 3.6 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.3 | 0.6 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.3 | 1.6 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
| 0.3 | 0.3 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
| 0.3 | 0.6 | GO:0034776 | response to histamine(GO:0034776) |
| 0.3 | 0.6 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
| 0.3 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.3 | 1.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
| 0.3 | 1.9 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.3 | 3.2 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
| 0.3 | 19.3 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.3 | 1.3 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 | 0.9 | GO:0035303 | regulation of dephosphorylation(GO:0035303) |
| 0.3 | 1.3 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.3 | 3.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 0.3 | 0.6 | GO:0045926 | negative regulation of growth(GO:0045926) |
| 0.3 | 0.3 | GO:1902065 | response to L-glutamate(GO:1902065) |
| 0.3 | 1.3 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
| 0.3 | 4.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.3 | 0.9 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 | 0.9 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.3 | 1.2 | GO:0000050 | urea cycle(GO:0000050) |
| 0.3 | 1.2 | GO:0001828 | inner cell mass cellular morphogenesis(GO:0001828) |
| 0.3 | 0.9 | GO:0060022 | hard palate development(GO:0060022) |
| 0.3 | 1.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.3 | 0.9 | GO:0046379 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
| 0.3 | 0.6 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
| 0.3 | 0.9 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.3 | 2.1 | GO:0042262 | DNA protection(GO:0042262) |
| 0.3 | 0.9 | GO:0097503 | sialylation(GO:0097503) |
| 0.3 | 1.2 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
| 0.3 | 0.9 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.3 | 7.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.3 | 0.3 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
| 0.3 | 9.7 | GO:1904659 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.3 | 2.4 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.3 | 14.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.3 | 0.3 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.3 | 1.2 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.3 | 10.0 | GO:0033046 | negative regulation of sister chromatid segregation(GO:0033046) negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of chromosome segregation(GO:0051985) |
| 0.3 | 0.3 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.3 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.3 | 1.5 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
| 0.3 | 2.1 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
| 0.3 | 6.0 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.3 | 2.1 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.3 | 0.9 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.3 | 0.3 | GO:0071706 | tumor necrosis factor superfamily cytokine production(GO:0071706) |
| 0.3 | 3.9 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.3 | 0.3 | GO:0007215 | glutamate receptor signaling pathway(GO:0007215) |
| 0.3 | 6.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
| 0.3 | 0.3 | GO:0000712 | resolution of meiotic recombination intermediates(GO:0000712) |
| 0.3 | 1.8 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
| 0.3 | 0.9 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 0.3 | 5.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.3 | 0.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 0.9 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
| 0.3 | 0.6 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.3 | 0.9 | GO:0090175 | Wnt signaling pathway, planar cell polarity pathway(GO:0060071) regulation of establishment of planar polarity(GO:0090175) |
| 0.3 | 0.9 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
| 0.3 | 0.9 | GO:0010458 | exit from mitosis(GO:0010458) |
| 0.3 | 0.9 | GO:1905205 | regulation of connective tissue replacement(GO:1905203) positive regulation of connective tissue replacement(GO:1905205) |
| 0.3 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 | 2.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 | 2.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.3 | 1.1 | GO:0006884 | cell volume homeostasis(GO:0006884) |
| 0.3 | 1.7 | GO:1901911 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 | 2.3 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.3 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.3 | 0.3 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
| 0.3 | 3.1 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
| 0.3 | 0.8 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.3 | 4.5 | GO:2001197 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.3 | 1.1 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 1.1 | GO:0070266 | necroptotic process(GO:0070266) |
| 0.3 | 0.6 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
| 0.3 | 1.9 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.3 | 1.9 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
| 0.3 | 0.8 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.3 | 12.9 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
| 0.3 | 0.6 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.3 | 3.6 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.3 | 4.1 | GO:0060732 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 | 1.4 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.3 | 2.7 | GO:0051026 | chiasma assembly(GO:0051026) |
| 0.3 | 1.4 | GO:0033233 | regulation of protein sumoylation(GO:0033233) |
| 0.3 | 1.1 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.3 | 0.8 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.3 | 0.5 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 0.3 | 1.4 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.3 | 0.8 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.3 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
| 0.3 | 0.8 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
| 0.3 | 0.8 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.3 | 1.1 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.3 | 1.1 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.3 | 5.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.3 | 1.1 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.3 | 20.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.3 | 1.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 0.3 | 0.3 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
| 0.3 | 1.3 | GO:0032808 | lacrimal gland development(GO:0032808) |
| 0.3 | 3.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
| 0.3 | 2.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.3 | 0.3 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
| 0.3 | 0.8 | GO:0072319 | vesicle uncoating(GO:0072319) |
| 0.3 | 4.5 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.3 | 1.6 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
| 0.3 | 1.0 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
| 0.3 | 0.5 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.3 | 0.5 | GO:0030101 | natural killer cell activation(GO:0030101) |
| 0.3 | 0.3 | GO:0046833 | positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.3 | 0.8 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.3 | 0.3 | GO:0050893 | sensory processing(GO:0050893) |
| 0.3 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 | 0.3 | GO:1903935 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.3 | 0.5 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.3 | 3.1 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.3 | 2.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.3 | 0.3 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
| 0.3 | 6.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
| 0.3 | 0.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.3 | 1.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.3 | 1.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.3 | 0.8 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 | 0.8 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.3 | 0.5 | GO:0010255 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
| 0.3 | 1.5 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.3 | 0.5 | GO:2000505 | regulation of energy homeostasis(GO:2000505) |
| 0.3 | 1.0 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
| 0.3 | 0.8 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.3 | 13.1 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
| 0.3 | 0.3 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.3 | 0.8 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.3 | 1.0 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.3 | 4.0 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.3 | 0.5 | GO:0040009 | regulation of growth rate(GO:0040009) |
| 0.3 | 0.5 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
| 0.3 | 1.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
| 0.3 | 5.0 | GO:0048240 | sperm capacitation(GO:0048240) |
| 0.2 | 0.5 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.2 | 1.0 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 | 0.7 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
| 0.2 | 1.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.2 | 3.5 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
| 0.2 | 1.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
| 0.2 | 0.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 5.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.2 | 0.2 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
| 0.2 | 3.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 | 0.2 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
| 0.2 | 3.0 | GO:1902592 | viral budding(GO:0046755) multi-organism organelle organization(GO:1902590) multi-organism membrane budding(GO:1902592) |
| 0.2 | 1.5 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 0.7 | GO:2000342 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.2 | 1.2 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
| 0.2 | 2.7 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 0.2 | 1.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 | 2.2 | GO:0034405 | response to fluid shear stress(GO:0034405) |
| 0.2 | 0.2 | GO:0045979 | positive regulation of nucleoside metabolic process(GO:0045979) positive regulation of ATP metabolic process(GO:1903580) |
| 0.2 | 1.0 | GO:0009227 | nucleotide-sugar catabolic process(GO:0009227) |
| 0.2 | 1.9 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.2 | 4.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.2 | 1.0 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
| 0.2 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) positive regulation of sperm motility(GO:1902093) |
| 0.2 | 0.7 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
| 0.2 | 2.6 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.2 | 1.0 | GO:0098868 | bone growth(GO:0098868) |
| 0.2 | 3.6 | GO:1903859 | regulation of dendrite extension(GO:1903859) positive regulation of dendrite extension(GO:1903861) |
| 0.2 | 2.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
| 0.2 | 1.4 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 17.9 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.2 | 1.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 0.9 | GO:0045950 | regulation of mitotic recombination(GO:0000019) negative regulation of mitotic recombination(GO:0045950) |
| 0.2 | 1.2 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
| 0.2 | 1.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 3.5 | GO:0097435 | fibril organization(GO:0097435) |
| 0.2 | 1.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 0.2 | 0.2 | GO:0051932 | synaptic transmission, GABAergic(GO:0051932) |
| 0.2 | 3.7 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.2 | 0.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 0.2 | 0.2 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 1.6 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.2 | 2.3 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.2 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
| 0.2 | 0.5 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.2 | 0.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.2 | 19.8 | GO:0042795 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.2 | 0.9 | GO:0001881 | receptor recycling(GO:0001881) |
| 0.2 | 0.5 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
| 0.2 | 0.5 | GO:0036337 | Fas signaling pathway(GO:0036337) |
| 0.2 | 5.0 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
| 0.2 | 1.1 | GO:0036120 | response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.2 | 0.2 | GO:0032649 | regulation of interferon-gamma production(GO:0032649) |
| 0.2 | 3.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.2 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.2 | 1.6 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 0.2 | 7.7 | GO:0046039 | GTP metabolic process(GO:0046039) |
| 0.2 | 1.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
| 0.2 | 0.5 | GO:0051344 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 | 0.7 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 | 1.6 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.2 | 1.6 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 0.9 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 | 0.7 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 | 1.1 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 | 0.7 | GO:0043574 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.2 | 0.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
| 0.2 | 1.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.2 | 0.7 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.2 | 0.2 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
| 0.2 | 3.9 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
| 0.2 | 0.9 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.2 | 0.9 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.2 | 0.7 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.2 | 0.2 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 | 12.6 | GO:0042058 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.2 | 0.6 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.2 | 0.4 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
| 0.2 | 2.6 | GO:0072595 | maintenance of protein localization in organelle(GO:0072595) |
| 0.2 | 0.9 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) vitamin D3 metabolic process(GO:0070640) |
| 0.2 | 0.4 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 0.2 | 5.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.2 | 0.2 | GO:0010390 | histone monoubiquitination(GO:0010390) |
| 0.2 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
| 0.2 | 0.4 | GO:0002931 | response to ischemia(GO:0002931) |
| 0.2 | 0.6 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.2 | 0.6 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
| 0.2 | 0.2 | GO:0007518 | myoblast fate determination(GO:0007518) |
| 0.2 | 1.7 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.2 | 0.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
| 0.2 | 1.0 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.2 | 1.0 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 0.2 | 0.8 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.2 | 2.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
| 0.2 | 0.6 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
| 0.2 | 0.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.2 | 1.9 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 | 1.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.2 | 1.7 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 0.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
| 0.2 | 0.2 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.2 | 2.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.2 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
| 0.2 | 0.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
| 0.2 | 0.2 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) |
| 0.2 | 4.9 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.2 | 0.8 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.2 | 0.8 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.2 | 2.2 | GO:0061577 | calcium ion transmembrane transport via high voltage-gated calcium channel(GO:0061577) |
| 0.2 | 1.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 0.2 | 0.8 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.2 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.2 | 0.2 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.2 | 0.8 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.2 | 0.6 | GO:0072553 | terminal button organization(GO:0072553) |
| 0.2 | 1.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.2 | 0.4 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.2 | 1.0 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 1.6 | GO:0007207 | phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.2 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
| 0.2 | 3.6 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.2 | 0.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
| 0.2 | 3.6 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.2 | 1.6 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.2 | GO:0046398 | UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.2 | 0.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
| 0.2 | 1.0 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 | 3.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.2 | 1.6 | GO:0043380 | memory T cell differentiation(GO:0043379) regulation of memory T cell differentiation(GO:0043380) |
| 0.2 | 3.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
| 0.2 | 0.6 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.2 | 8.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.2 | 0.4 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
| 0.2 | 1.3 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 | 0.6 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
| 0.2 | 0.8 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.2 | 0.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
| 0.2 | 0.8 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
| 0.2 | 1.0 | GO:0035878 | nail development(GO:0035878) |
| 0.2 | 1.3 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.2 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.2 | 10.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.2 | 0.4 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
| 0.2 | 0.2 | GO:0014721 | voluntary skeletal muscle contraction(GO:0003010) twitch skeletal muscle contraction(GO:0014721) |
| 0.2 | 3.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.2 | 0.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.2 | 1.3 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.2 | 1.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.2 | 0.6 | GO:1904640 | response to methionine(GO:1904640) |
| 0.2 | 0.2 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.2 | 0.2 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
| 0.2 | 5.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
| 0.2 | 0.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.2 | 0.7 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
| 0.2 | 2.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 0.2 | 0.2 | GO:0007569 | cell aging(GO:0007569) |
| 0.2 | 1.1 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.2 | 0.4 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
| 0.2 | 0.4 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.2 | 0.4 | GO:0048588 | developmental cell growth(GO:0048588) |
| 0.2 | 4.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.2 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.2 | 4.1 | GO:0050919 | negative chemotaxis(GO:0050919) |
| 0.2 | 1.2 | GO:0033008 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.2 | 0.4 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.2 | 0.4 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.2 | 0.5 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.2 | 0.4 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.2 | 0.4 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.2 | 0.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
| 0.2 | 0.2 | GO:0022410 | circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.2 | 0.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.2 | 5.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.2 | 4.0 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
| 0.2 | 6.6 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
| 0.2 | 0.2 | GO:0033619 | membrane protein proteolysis(GO:0033619) |
| 0.2 | 0.7 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.2 | 1.2 | GO:0051875 | pigment granule localization(GO:0051875) |
| 0.2 | 0.9 | GO:0042426 | choline catabolic process(GO:0042426) |
| 0.2 | 1.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
| 0.2 | 0.5 | GO:0051934 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
| 0.2 | 1.2 | GO:0051412 | response to corticosterone(GO:0051412) |
| 0.2 | 2.2 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
| 0.2 | 2.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.2 | 0.3 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
| 0.2 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
| 0.2 | 0.7 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.2 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
| 0.2 | 7.2 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.2 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.2 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
| 0.2 | 0.3 | GO:2001201 | regulation of transforming growth factor-beta secretion(GO:2001201) |
| 0.2 | 0.2 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
| 0.2 | 0.3 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.2 | 1.0 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.2 | 1.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
| 0.2 | 1.5 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
| 0.2 | 2.0 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.2 | 0.3 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
| 0.2 | 0.5 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 | 1.2 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
| 0.2 | 2.2 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.2 | 1.3 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 | 0.5 | GO:2000179 | positive regulation of neural precursor cell proliferation(GO:2000179) |
| 0.2 | 1.0 | GO:0032468 | Golgi calcium ion homeostasis(GO:0032468) |
| 0.2 | 2.0 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
| 0.2 | 0.2 | GO:0098501 | polynucleotide dephosphorylation(GO:0098501) |
| 0.2 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 0.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
| 0.2 | 0.5 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
| 0.2 | 0.3 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
| 0.2 | 0.2 | GO:0006561 | proline biosynthetic process(GO:0006561) |
| 0.2 | 0.7 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
| 0.2 | 1.6 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.2 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.2 | 1.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
| 0.2 | 3.5 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.2 | 0.2 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.2 | 0.2 | GO:1901491 | regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 0.2 | 0.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 0.2 | 1.1 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
| 0.2 | 0.5 | GO:0071504 | cellular response to heparin(GO:0071504) |
| 0.2 | 1.6 | GO:0009304 | tRNA transcription(GO:0009304) |
| 0.2 | 1.7 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.2 | 0.2 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.2 | 0.5 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
| 0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
| 0.2 | 1.4 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.2 | 0.2 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) |
| 0.2 | 2.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.2 | 2.9 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.2 | 0.5 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
| 0.2 | 3.2 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.2 | 0.6 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 0.5 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.2 | 2.0 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.2 | 0.8 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.2 | 0.2 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
| 0.2 | 0.5 | GO:1904379 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
| 0.2 | 1.2 | GO:0097118 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.2 | 0.8 | GO:0030890 | positive regulation of B cell proliferation(GO:0030890) |
| 0.2 | 0.3 | GO:0071941 | nitrogen cycle metabolic process(GO:0071941) |
| 0.2 | 0.3 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.2 | 0.8 | GO:0007028 | cytoplasm organization(GO:0007028) |
| 0.2 | 0.2 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 0.2 | 0.3 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
| 0.1 | 0.3 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.1 | 10.8 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.1 | 1.2 | GO:0007272 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
| 0.1 | 0.4 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
| 0.1 | 0.1 | GO:0090003 | regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.1 | 1.8 | GO:0015837 | amine transport(GO:0015837) |
| 0.1 | 0.4 | GO:0050777 | negative regulation of immune response(GO:0050777) |
| 0.1 | 0.9 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.1 | 1.3 | GO:0030220 | platelet formation(GO:0030220) |
| 0.1 | 0.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.1 | 0.1 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 | 2.5 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.1 | 0.3 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
| 0.1 | 0.3 | GO:0000432 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
| 0.1 | 0.3 | GO:0015864 | pyrimidine nucleoside transport(GO:0015864) |
| 0.1 | 0.3 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 0.1 | 3.0 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.1 | 0.9 | GO:0090257 | regulation of muscle system process(GO:0090257) |
| 0.1 | 0.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.1 | 0.9 | GO:0071539 | protein localization to centrosome(GO:0071539) |
| 0.1 | 0.1 | GO:0060438 | trachea development(GO:0060438) |
| 0.1 | 0.9 | GO:0030210 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
| 0.1 | 3.4 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 | 4.4 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 5.0 | GO:0070527 | platelet aggregation(GO:0070527) |
| 0.1 | 0.3 | GO:0042130 | negative regulation of T cell proliferation(GO:0042130) |
| 0.1 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 0.1 | 5.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.1 | 0.6 | GO:0009650 | UV protection(GO:0009650) |
| 0.1 | 0.7 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.1 | 3.1 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.1 | 0.1 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 | 0.7 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.1 | 0.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
| 0.1 | 0.1 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
| 0.1 | 6.8 | GO:0006939 | smooth muscle contraction(GO:0006939) |
| 0.1 | 0.3 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.1 | 0.4 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 | 0.3 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.1 | 0.3 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
| 0.1 | 1.2 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.1 | 0.1 | GO:0097187 | dentinogenesis(GO:0097187) |
| 0.1 | 0.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.1 | 1.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.4 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 0.1 | 0.1 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.1 | 5.3 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) |
| 0.1 | 3.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.1 | 6.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.1 | 0.1 | GO:0042092 | type 2 immune response(GO:0042092) |
| 0.1 | 0.4 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.1 | 0.9 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
| 0.1 | 1.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.1 | 1.7 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 | 1.2 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
| 0.1 | 0.8 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 | 1.2 | GO:0030091 | protein repair(GO:0030091) |
| 0.1 | 0.1 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
| 0.1 | 0.4 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.1 | 0.3 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
| 0.1 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
| 0.1 | 0.4 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
| 0.1 | 0.3 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
| 0.1 | 0.4 | GO:0055006 | cardiac cell development(GO:0055006) |
| 0.1 | 0.5 | GO:0045974 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.1 | 0.3 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.1 | 1.7 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.4 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.1 | 0.5 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 1.3 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.1 | 0.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.4 | GO:0035909 | aorta morphogenesis(GO:0035909) |
| 0.1 | 0.6 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.1 | 0.3 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
| 0.1 | 1.0 | GO:0042670 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.1 | 0.1 | GO:0051216 | cartilage development(GO:0051216) |
| 0.1 | 2.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.3 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 0.1 | 0.5 | GO:1900248 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
| 0.1 | 3.5 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
| 0.1 | 4.1 | GO:0033260 | nuclear DNA replication(GO:0033260) |
| 0.1 | 2.4 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
| 0.1 | 3.1 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 0.1 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
| 0.1 | 3.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 1.0 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 1.0 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.1 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 0.1 | 3.3 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.1 | 0.2 | GO:0002067 | glandular epithelial cell differentiation(GO:0002067) |
| 0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 0.1 | 0.4 | GO:1903146 | regulation of mitophagy(GO:1903146) |
| 0.1 | 0.1 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 | 0.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 0.1 | 0.1 | GO:0071287 | response to manganese ion(GO:0010042) cellular response to manganese ion(GO:0071287) |
| 0.1 | 0.6 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
| 0.1 | 0.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 2.3 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.7 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.1 | 0.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.1 | 0.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.1 | 0.2 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 | 3.0 | GO:0030516 | regulation of axon extension(GO:0030516) |
| 0.1 | 0.8 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 0.7 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.1 | 0.1 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
| 0.1 | 1.1 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.1 | 1.2 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
| 0.1 | 1.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 1.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 0.5 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 0.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
| 0.1 | 1.7 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
| 0.1 | 0.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 | 0.9 | GO:0034378 | chylomicron assembly(GO:0034378) |
| 0.1 | 0.2 | GO:0033198 | response to ATP(GO:0033198) |
| 0.1 | 0.2 | GO:0051954 | positive regulation of amine transport(GO:0051954) |
| 0.1 | 0.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 0.1 | 0.7 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.1 | 0.3 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.6 | GO:0048103 | somatic stem cell division(GO:0048103) |
| 0.1 | 0.7 | GO:0021794 | thalamus development(GO:0021794) |
| 0.1 | 0.3 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
| 0.1 | 0.8 | GO:0030903 | notochord development(GO:0030903) |
| 0.1 | 0.2 | GO:0021764 | amygdala development(GO:0021764) |
| 0.1 | 0.1 | GO:0050885 | neuromuscular process controlling balance(GO:0050885) |
| 0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 | 0.6 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
| 0.1 | 0.3 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.1 | 3.0 | GO:0006308 | DNA catabolic process(GO:0006308) |
| 0.1 | 0.3 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.1 | 0.2 | GO:0042310 | vasoconstriction(GO:0042310) |
| 0.1 | 0.9 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 | 0.8 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.4 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 | 0.2 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
| 0.1 | 0.9 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.1 | 1.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 0.2 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.1 | 0.3 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
| 0.1 | 0.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
| 0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
| 0.1 | 1.1 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.1 | 1.7 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.1 | 0.2 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.1 | 1.0 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.1 | 0.2 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.1 | 1.7 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 | 0.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
| 0.1 | 1.0 | GO:2000347 | positive regulation of hepatocyte proliferation(GO:2000347) |
| 0.1 | 0.6 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.1 | 0.2 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 0.1 | 0.9 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 | 0.3 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.3 | GO:0002818 | intracellular defense response(GO:0002818) |
| 0.1 | 0.6 | GO:0030421 | defecation(GO:0030421) |
| 0.1 | 0.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.1 | 0.7 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.1 | 0.3 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.1 | 0.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
| 0.1 | 0.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.1 | 0.4 | GO:0060326 | cell chemotaxis(GO:0060326) |
| 0.1 | 0.2 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.1 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
| 0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.1 | 3.3 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.1 | 0.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.1 | 0.6 | GO:0016050 | vesicle organization(GO:0016050) |
| 0.1 | 0.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.1 | 0.9 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
| 0.1 | 2.2 | GO:0005980 | glycogen catabolic process(GO:0005980) |
| 0.1 | 0.4 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.1 | 0.7 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
| 0.1 | 0.3 | GO:0060065 | uterus development(GO:0060065) |
| 0.1 | 0.4 | GO:0070316 | regulation of G0 to G1 transition(GO:0070316) |
| 0.1 | 0.7 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.1 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.1 | 1.9 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.1 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.1 | 9.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 1.7 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.1 | 0.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.1 | 0.3 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
| 0.1 | 0.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
| 0.1 | 0.5 | GO:0031342 | negative regulation of cell killing(GO:0031342) |
| 0.1 | 0.4 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
| 0.1 | 1.9 | GO:0019233 | sensory perception of pain(GO:0019233) |
| 0.1 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.1 | 0.3 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
| 0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.1 | 1.4 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) |
| 0.1 | 0.9 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.1 | 1.6 | GO:0001825 | blastocyst formation(GO:0001825) |
| 0.1 | 0.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
| 0.1 | 0.8 | GO:0001964 | startle response(GO:0001964) |
| 0.1 | 0.3 | GO:0071395 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) |
| 0.1 | 0.5 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 | 0.3 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
| 0.1 | 0.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.1 | 0.4 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.1 | 0.2 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.1 | 0.1 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
| 0.1 | 0.2 | GO:0002456 | T cell mediated immunity(GO:0002456) |
| 0.1 | 0.7 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 | 0.2 | GO:0007501 | mesodermal cell fate specification(GO:0007501) |
| 0.1 | 0.1 | GO:0043255 | regulation of carbohydrate biosynthetic process(GO:0043255) |
| 0.1 | 0.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
| 0.1 | 0.2 | GO:0035511 | oxidative DNA demethylation(GO:0035511) regulation of DNA N-glycosylase activity(GO:1902544) |
| 0.1 | 1.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.1 | 0.2 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 | 0.8 | GO:0061053 | somite development(GO:0061053) |
| 0.1 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.1 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 0.1 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
| 0.1 | 2.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
| 0.1 | 1.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 | 0.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
| 0.1 | 0.5 | GO:0090218 | positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 | 0.5 | GO:0003091 | renal water homeostasis(GO:0003091) |
| 0.1 | 0.2 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.1 | 0.3 | GO:0031112 | positive regulation of microtubule polymerization or depolymerization(GO:0031112) |
| 0.1 | 0.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.4 | GO:1901523 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
| 0.1 | 0.3 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.1 | 0.2 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.1 | 0.1 | GO:0002418 | immune response to tumor cell(GO:0002418) |
| 0.1 | 0.4 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.1 | 1.4 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
| 0.1 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
| 0.1 | 0.1 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 0.1 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 | 0.2 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.1 | 0.5 | GO:1901989 | positive regulation of cell cycle phase transition(GO:1901989) |
| 0.1 | 0.2 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.1 | 0.6 | GO:0021670 | lateral ventricle development(GO:0021670) |
| 0.1 | 0.1 | GO:1904823 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.1 | 0.2 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.1 | 0.1 | GO:0009157 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) |
| 0.1 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
| 0.1 | 0.1 | GO:0097091 | synaptic vesicle clustering(GO:0097091) |
| 0.1 | 0.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.1 | 0.4 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
| 0.1 | 0.3 | GO:0010975 | regulation of neuron projection development(GO:0010975) |
| 0.1 | 1.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.1 | 0.1 | GO:0045471 | response to ethanol(GO:0045471) |
| 0.1 | 0.1 | GO:0035411 | catenin import into nucleus(GO:0035411) |
| 0.1 | 0.3 | GO:0051604 | protein maturation(GO:0051604) |
| 0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.1 | 0.6 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.1 | 0.1 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
| 0.1 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.1 | 0.1 | GO:0006533 | aspartate catabolic process(GO:0006533) |
| 0.1 | 0.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.1 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
| 0.1 | 0.2 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 0.1 | 0.1 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
| 0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.1 | 1.0 | GO:0044804 | nucleophagy(GO:0044804) |
| 0.1 | 0.1 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
| 0.1 | 0.7 | GO:0090342 | regulation of cell aging(GO:0090342) |
| 0.1 | 0.1 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.1 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 0.3 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.1 | 0.7 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
| 0.1 | 0.4 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.1 | 0.9 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
| 0.1 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.1 | 0.2 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
| 0.1 | 0.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 0.8 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 1.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
| 0.1 | 0.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
| 0.1 | 0.3 | GO:0032218 | riboflavin transport(GO:0032218) |
| 0.1 | 0.4 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
| 0.1 | 0.2 | GO:0090527 | actin filament reorganization(GO:0090527) |
| 0.1 | 0.6 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
| 0.1 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 | 0.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) |
| 0.1 | 0.4 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 | 0.1 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 8.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
| 0.1 | 0.1 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 | 0.1 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
| 0.1 | 0.8 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
| 0.1 | 0.3 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
| 0.1 | 0.2 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
| 0.1 | 0.1 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
| 0.1 | 0.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 | 0.1 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 | 0.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.2 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.1 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
| 0.1 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 25.3 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
| 0.1 | 0.1 | GO:0071875 | adrenergic receptor signaling pathway(GO:0071875) |
| 0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.1 | 0.2 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.1 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
| 0.1 | 0.2 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
| 0.1 | 0.3 | GO:0060324 | face development(GO:0060324) |
| 0.1 | 0.7 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
| 0.1 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 | 0.8 | GO:0034629 | cellular protein complex localization(GO:0034629) |
| 0.1 | 0.3 | GO:0001952 | regulation of cell-matrix adhesion(GO:0001952) |
| 0.1 | 0.3 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
| 0.1 | 0.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
| 0.1 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
| 0.1 | 0.5 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
| 0.1 | 0.1 | GO:0036093 | male germ cell proliferation(GO:0002176) germ cell proliferation(GO:0036093) |
| 0.1 | 0.1 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.1 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.1 | 2.3 | GO:2000117 | negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.1 | 0.1 | GO:0019086 | early viral transcription(GO:0019085) late viral transcription(GO:0019086) |
| 0.1 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.1 | 0.2 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.1 | 0.1 | GO:0008356 | asymmetric cell division(GO:0008356) |
| 0.1 | 0.1 | GO:1900736 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) |
| 0.1 | 0.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.1 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.0 | 0.4 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
| 0.0 | 0.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
| 0.0 | 0.5 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 | 0.1 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.0 | 0.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
| 0.0 | 0.1 | GO:1990414 | replication-born double-strand break repair via sister chromatid exchange(GO:1990414) |
| 0.0 | 0.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.2 | GO:0032740 | positive regulation of interleukin-17 production(GO:0032740) |
| 0.0 | 0.8 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.0 | 0.3 | GO:0071340 | skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.0 | 0.0 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 | 0.3 | GO:0035809 | regulation of urine volume(GO:0035809) |
| 0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
| 0.0 | 0.1 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.0 | 0.3 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 0.0 | 0.1 | GO:0010533 | regulation of activation of Janus kinase activity(GO:0010533) |
| 0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
| 0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
| 0.0 | 0.5 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 0.0 | 0.3 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.0 | 0.0 | GO:0071071 | regulation of phospholipid biosynthetic process(GO:0071071) |
| 0.0 | 0.4 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
| 0.0 | 0.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.0 | 0.2 | GO:0098876 | vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.0 | 0.1 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.0 | 0.3 | GO:0031167 | rRNA methylation(GO:0031167) |
| 0.0 | 0.6 | GO:0007041 | lysosomal transport(GO:0007041) |
| 0.0 | 0.0 | GO:0022616 | DNA strand elongation(GO:0022616) |
| 0.0 | 1.0 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.5 | GO:0042177 | negative regulation of protein catabolic process(GO:0042177) |
| 0.0 | 0.0 | GO:0014891 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) striated muscle atrophy(GO:0014891) |
| 0.0 | 0.1 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
| 0.0 | 0.1 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 | 0.0 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.0 | 0.2 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
| 0.0 | 0.5 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.1 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.0 | 0.1 | GO:0010044 | response to aluminum ion(GO:0010044) |
| 0.0 | 2.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 | 0.1 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
| 0.0 | 0.1 | GO:0048872 | homeostasis of number of cells(GO:0048872) |
| 0.0 | 0.0 | GO:0007620 | copulation(GO:0007620) |
| 0.0 | 0.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
| 0.0 | 0.6 | GO:0002223 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 0.1 | GO:0002526 | acute inflammatory response(GO:0002526) |
| 0.0 | 0.2 | GO:0052697 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
| 0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 | 0.0 | GO:0010888 | negative regulation of lipid storage(GO:0010888) |
| 0.0 | 0.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
| 0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.0 | 0.0 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
| 0.0 | 0.1 | GO:0052150 | modulation by symbiont of host apoptotic process(GO:0052150) |
| 0.0 | 0.1 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.0 | 0.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
| 0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.0 | 0.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
| 0.0 | 0.2 | GO:0099515 | actin filament-based transport(GO:0099515) |
| 0.0 | 0.1 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
| 0.0 | 0.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.0 | 0.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.0 | 0.1 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.0 | 0.0 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.0 | 0.0 | GO:0006880 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.0 | 0.0 | GO:0001832 | blastocyst growth(GO:0001832) |
| 0.0 | 0.0 | GO:1903573 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
| 0.0 | 0.1 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
| 0.0 | 0.2 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
| 0.0 | 0.2 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.0 | 0.7 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.0 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 0.0 | 0.1 | GO:2000779 | regulation of double-strand break repair(GO:2000779) |
| 0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
| 0.0 | 0.2 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
| 0.0 | 0.0 | GO:0072170 | metanephric tubule development(GO:0072170) |
| 0.0 | 0.0 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.0 | 0.0 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
| 0.0 | 0.0 | GO:0090656 | t-circle formation(GO:0090656) |
| 0.0 | 0.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.0 | 0.0 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
| 0.0 | 0.1 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
| 0.0 | 0.6 | GO:1902403 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
| 0.0 | 0.1 | GO:0030282 | bone mineralization(GO:0030282) |
| 0.0 | 0.1 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
| 0.0 | 0.7 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.0 | 0.1 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
| 0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.0 | GO:0006801 | superoxide metabolic process(GO:0006801) |
| 0.0 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 | 0.0 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
| 0.0 | 0.2 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 0.1 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) negative regulation of complement activation, classical pathway(GO:0045959) |
| 0.0 | 0.0 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
| 0.0 | 0.0 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
| 0.0 | 0.2 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 | 0.1 | GO:0007340 | acrosome reaction(GO:0007340) |
| 0.0 | 0.1 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.0 | 0.0 | GO:1904871 | regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) |
| 0.0 | 0.1 | GO:0071695 | anatomical structure maturation(GO:0071695) |
| 0.0 | 0.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.0 | 0.1 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 0.0 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
| 0.0 | 0.0 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.0 | 0.1 | GO:0032409 | regulation of transporter activity(GO:0032409) |
| 0.0 | 0.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 | 0.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
| 0.0 | 0.0 | GO:1900005 | positive regulation of serine-type endopeptidase activity(GO:1900005) positive regulation of serine-type peptidase activity(GO:1902573) |
| 0.0 | 0.0 | GO:0002076 | osteoblast development(GO:0002076) |
| 0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 | 0.1 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.0 | 0.1 | GO:0042113 | B cell activation(GO:0042113) |
| 0.0 | 0.0 | GO:0051775 | response to redox state(GO:0051775) |
| 0.0 | 0.0 | GO:0014859 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
| 0.0 | 0.0 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.7 | 20.0 | GO:0031523 | Myb complex(GO:0031523) |
| 6.6 | 46.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
| 3.9 | 19.7 | GO:0032449 | CBM complex(GO:0032449) |
| 3.3 | 9.8 | GO:0071065 | alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex(GO:0071065) |
| 2.6 | 7.9 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
| 2.4 | 2.4 | GO:0000806 | Y chromosome(GO:0000806) |
| 2.3 | 9.2 | GO:0045160 | myosin I complex(GO:0045160) |
| 2.1 | 6.4 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
| 2.0 | 10.2 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
| 1.9 | 9.4 | GO:0070876 | SOSS complex(GO:0070876) |
| 1.9 | 11.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.8 | 7.3 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 1.8 | 5.4 | GO:1990666 | PCSK9-LDLR complex(GO:1990666) |
| 1.7 | 8.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 1.7 | 33.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 1.7 | 6.9 | GO:0043293 | apoptosome(GO:0043293) |
| 1.6 | 39.1 | GO:0005861 | troponin complex(GO:0005861) |
| 1.6 | 4.9 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 1.6 | 4.8 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
| 1.6 | 15.9 | GO:0000796 | condensin complex(GO:0000796) |
| 1.6 | 11.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 1.6 | 6.2 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
| 1.5 | 10.7 | GO:0032437 | cuticular plate(GO:0032437) |
| 1.5 | 4.4 | GO:0005668 | RNA polymerase transcription factor SL1 complex(GO:0005668) |
| 1.5 | 19.2 | GO:0008091 | spectrin(GO:0008091) |
| 1.5 | 14.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 1.4 | 35.4 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
| 1.4 | 28.2 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.4 | 5.5 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
| 1.4 | 32.9 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 1.4 | 4.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 1.3 | 8.0 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.3 | 7.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 1.3 | 11.9 | GO:0098645 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
| 1.3 | 1.3 | GO:0098794 | postsynapse(GO:0098794) |
| 1.3 | 5.2 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
| 1.3 | 2.6 | GO:0014802 | terminal cisterna(GO:0014802) |
| 1.2 | 6.2 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 1.2 | 3.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 1.2 | 17.5 | GO:0031209 | SCAR complex(GO:0031209) |
| 1.2 | 24.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 1.2 | 9.2 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 1.1 | 3.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 1.1 | 5.6 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
| 1.1 | 1.1 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
| 1.1 | 4.5 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 1.1 | 5.5 | GO:0044393 | microspike(GO:0044393) |
| 1.1 | 9.9 | GO:0097443 | sorting endosome(GO:0097443) |
| 1.1 | 5.5 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.0 | 3.1 | GO:1990031 | pinceau fiber(GO:1990031) |
| 1.0 | 9.2 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 1.0 | 4.0 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
| 1.0 | 8.0 | GO:0070938 | contractile ring(GO:0070938) |
| 1.0 | 6.0 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 1.0 | 4.0 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 1.0 | 3.9 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 1.0 | 8.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.0 | 11.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.0 | 1.0 | GO:0072563 | endothelial microparticle(GO:0072563) |
| 1.0 | 3.8 | GO:0031261 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
| 0.9 | 0.9 | GO:0034681 | integrin alpha11-beta1 complex(GO:0034681) |
| 0.9 | 4.7 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
| 0.9 | 7.5 | GO:0051286 | cell tip(GO:0051286) |
| 0.9 | 2.8 | GO:1990015 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
| 0.9 | 4.6 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 0.9 | 1.8 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.9 | 0.9 | GO:0005607 | laminin-2 complex(GO:0005607) |
| 0.9 | 3.5 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.9 | 3.5 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
| 0.9 | 5.2 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
| 0.9 | 2.6 | GO:0098855 | HCN channel complex(GO:0098855) |
| 0.8 | 5.9 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.8 | 2.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.8 | 5.7 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.8 | 13.0 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.8 | 3.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.8 | 3.2 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
| 0.8 | 5.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.8 | 2.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
| 0.8 | 3.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
| 0.8 | 5.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.8 | 3.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.8 | 26.7 | GO:0030057 | desmosome(GO:0030057) |
| 0.8 | 3.0 | GO:0030934 | anchoring collagen complex(GO:0030934) |
| 0.8 | 6.1 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.8 | 2.3 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.7 | 0.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 0.7 | 20.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.7 | 7.4 | GO:0030478 | actin cap(GO:0030478) |
| 0.7 | 2.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.7 | 6.5 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.7 | 2.9 | GO:0031417 | NatC complex(GO:0031417) |
| 0.7 | 8.7 | GO:0043219 | lateral loop(GO:0043219) |
| 0.7 | 3.6 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 0.7 | 8.0 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.7 | 3.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.7 | 2.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 0.7 | 5.7 | GO:0036128 | CatSper complex(GO:0036128) |
| 0.7 | 5.7 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.7 | 4.3 | GO:0036449 | microtubule minus-end(GO:0036449) |
| 0.7 | 6.9 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.7 | 2.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.7 | 2.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.7 | 12.3 | GO:0090543 | Flemming body(GO:0090543) |
| 0.7 | 4.0 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.7 | 8.7 | GO:0005865 | striated muscle thin filament(GO:0005865) |
| 0.7 | 16.1 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.7 | 0.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.7 | 17.9 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.7 | 5.3 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.7 | 0.7 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 0.7 | 4.6 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.7 | 42.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.7 | 21.6 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.6 | 0.6 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.6 | 0.6 | GO:0032421 | stereocilium bundle(GO:0032421) |
| 0.6 | 1.3 | GO:0016589 | NURF complex(GO:0016589) |
| 0.6 | 15.0 | GO:0030424 | axon(GO:0030424) |
| 0.6 | 33.4 | GO:0002102 | podosome(GO:0002102) |
| 0.6 | 14.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
| 0.6 | 44.9 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
| 0.6 | 3.0 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.6 | 5.4 | GO:0098845 | postsynaptic endosome(GO:0098845) |
| 0.6 | 3.0 | GO:0044308 | axonal spine(GO:0044308) |
| 0.6 | 4.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.6 | 1.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.6 | 4.0 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.6 | 4.0 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.6 | 1.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
| 0.6 | 3.9 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.6 | 2.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
| 0.6 | 1.1 | GO:0097450 | astrocyte end-foot(GO:0097450) |
| 0.5 | 58.0 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.5 | 2.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.5 | 1.6 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.5 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.5 | 3.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.5 | 3.5 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.5 | 4.5 | GO:0005638 | lamin filament(GO:0005638) |
| 0.5 | 6.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
| 0.5 | 3.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.5 | 18.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.5 | 3.9 | GO:0031415 | NatA complex(GO:0031415) |
| 0.5 | 1.5 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.5 | 3.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.5 | 4.4 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.5 | 3.4 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.5 | 1.9 | GO:0033011 | perinuclear theca(GO:0033011) |
| 0.5 | 2.4 | GO:0032021 | NELF complex(GO:0032021) |
| 0.5 | 34.2 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
| 0.5 | 1.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.5 | 7.6 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.5 | 0.9 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
| 0.5 | 2.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.5 | 8.5 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 0.5 | 18.5 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.5 | 0.9 | GO:0055087 | Ski complex(GO:0055087) |
| 0.5 | 1.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.5 | 3.7 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.5 | 0.5 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.5 | 14.2 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.5 | 1.8 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
| 0.4 | 7.2 | GO:0060077 | inhibitory synapse(GO:0060077) |
| 0.4 | 1.8 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.4 | 4.0 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.4 | 2.2 | GO:0031905 | early endosome lumen(GO:0031905) |
| 0.4 | 3.9 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.4 | 11.8 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.4 | 12.0 | GO:0043034 | costamere(GO:0043034) |
| 0.4 | 1.3 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
| 0.4 | 2.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.4 | 6.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.4 | 26.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.4 | 3.7 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.4 | 0.4 | GO:0097433 | dense body(GO:0097433) |
| 0.4 | 0.8 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.4 | 1.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.4 | 2.8 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
| 0.4 | 6.0 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.4 | 2.4 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
| 0.4 | 22.2 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.4 | 32.5 | GO:1904724 | tertiary granule lumen(GO:1904724) |
| 0.4 | 3.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.4 | 7.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.4 | 2.3 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.4 | 6.2 | GO:0042555 | MCM complex(GO:0042555) |
| 0.4 | 7.3 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.4 | 7.7 | GO:0010369 | chromocenter(GO:0010369) |
| 0.4 | 13.3 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.4 | 3.4 | GO:0071546 | pi-body(GO:0071546) |
| 0.4 | 3.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
| 0.4 | 1.1 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 0.4 | 5.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.4 | 2.6 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.4 | 2.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.4 | 3.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.4 | 3.0 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 3.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.4 | 1.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.4 | 1.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
| 0.4 | 3.3 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
| 0.4 | 0.7 | GO:1990742 | microvesicle(GO:1990742) |
| 0.4 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.4 | 2.2 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
| 0.4 | 1.1 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
| 0.4 | 0.4 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
| 0.4 | 1.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 0.4 | 1.8 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.4 | 2.8 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.4 | 1.4 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.4 | 0.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.4 | 2.8 | GO:0045180 | basal cortex(GO:0045180) |
| 0.3 | 35.0 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.3 | 1.4 | GO:0019031 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
| 0.3 | 1.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.3 | 0.3 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.3 | 2.4 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.3 | 6.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.3 | 5.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.3 | 1.0 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 0.3 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.3 | 1.7 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.3 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
| 0.3 | 0.7 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
| 0.3 | 1.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 0.3 | 1.0 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.3 | 1.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.3 | 10.7 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
| 0.3 | 0.3 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.3 | 22.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.3 | 1.6 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.3 | 4.8 | GO:0005902 | microvillus(GO:0005902) |
| 0.3 | 0.6 | GO:0044326 | dendritic spine neck(GO:0044326) |
| 0.3 | 28.8 | GO:0005901 | caveola(GO:0005901) |
| 0.3 | 10.0 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.3 | 2.8 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.3 | 1.2 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 6.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 23.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
| 0.3 | 0.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
| 0.3 | 2.1 | GO:0032059 | bleb(GO:0032059) |
| 0.3 | 2.7 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
| 0.3 | 25.0 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.3 | 9.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.3 | 2.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.3 | 0.3 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.3 | 1.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 0.3 | 39.2 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 0.3 | 0.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.3 | 1.1 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.3 | 1.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
| 0.3 | 0.9 | GO:0044327 | dendritic spine head(GO:0044327) |
| 0.3 | 0.8 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.3 | 0.8 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
| 0.3 | 8.2 | GO:0000145 | exocyst(GO:0000145) |
| 0.3 | 1.4 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 1.1 | GO:0036021 | endolysosome lumen(GO:0036021) |
| 0.3 | 6.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.3 | 0.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.3 | 12.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.3 | 2.2 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.3 | 1.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.3 | 0.3 | GO:0097165 | nuclear stress granule(GO:0097165) |
| 0.3 | 1.3 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.3 | 1.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 0.3 | 1.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.3 | 3.4 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.3 | 0.8 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
| 0.3 | 4.1 | GO:0046930 | pore complex(GO:0046930) |
| 0.3 | 0.3 | GO:1903349 | omegasome membrane(GO:1903349) |
| 0.3 | 0.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
| 0.3 | 0.8 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.3 | 6.0 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
| 0.3 | 3.3 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.3 | 22.5 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.2 | 7.2 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.2 | 20.1 | GO:0018995 | host(GO:0018995) host cell(GO:0043657) |
| 0.2 | 0.5 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
| 0.2 | 7.6 | GO:0030673 | axolemma(GO:0030673) |
| 0.2 | 4.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.2 | 21.5 | GO:0005811 | lipid particle(GO:0005811) |
| 0.2 | 1.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 2.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 4.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 0.7 | GO:0030894 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
| 0.2 | 30.9 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.2 | 26.8 | GO:0070821 | tertiary granule membrane(GO:0070821) |
| 0.2 | 2.1 | GO:0070187 | telosome(GO:0070187) |
| 0.2 | 0.7 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.7 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
| 0.2 | 0.7 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
| 0.2 | 6.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 0.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.2 | 0.5 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.2 | 3.4 | GO:0044232 | organelle membrane contact site(GO:0044232) |
| 0.2 | 0.2 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 0.2 | 8.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.2 | 0.7 | GO:0097447 | dendritic tree(GO:0097447) |
| 0.2 | 0.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
| 0.2 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.2 | 7.1 | GO:0045171 | intercellular bridge(GO:0045171) |
| 0.2 | 2.7 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.2 | 3.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.2 | 0.4 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
| 0.2 | 0.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.2 | 0.7 | GO:0035339 | SPOTS complex(GO:0035339) |
| 0.2 | 19.2 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.2 | 1.9 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.2 | 0.2 | GO:0005713 | recombination nodule(GO:0005713) |
| 0.2 | 1.5 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.2 | 34.7 | GO:0030027 | lamellipodium(GO:0030027) |
| 0.2 | 0.4 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.2 | 2.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.2 | 1.1 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
| 0.2 | 0.2 | GO:1990462 | omegasome(GO:1990462) |
| 0.2 | 3.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.2 | 1.7 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 3.7 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.2 | 18.3 | GO:0000776 | kinetochore(GO:0000776) |
| 0.2 | 0.8 | GO:0043203 | axon hillock(GO:0043203) |
| 0.2 | 1.6 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.2 | 1.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.2 | 4.5 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 0.2 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.2 | 1.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.2 | 1.2 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.2 | 2.3 | GO:0030426 | growth cone(GO:0030426) |
| 0.2 | 0.6 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.2 | 0.6 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.2 | 1.5 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.2 | 0.8 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 0.6 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.2 | 0.6 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.2 | 6.5 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.2 | 0.7 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.2 | 6.7 | GO:0001726 | ruffle(GO:0001726) |
| 0.2 | 0.4 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.2 | 1.3 | GO:0033503 | HULC complex(GO:0033503) |
| 0.2 | 0.5 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.2 | 1.6 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.2 | 1.8 | GO:0043296 | apical junction complex(GO:0043296) |
| 0.2 | 1.8 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.2 | 1.6 | GO:0001741 | XY body(GO:0001741) |
| 0.2 | 0.5 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
| 0.2 | 0.7 | GO:0045179 | apical cortex(GO:0045179) |
| 0.2 | 3.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.2 | 0.5 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.2 | 0.9 | GO:0005770 | late endosome(GO:0005770) |
| 0.2 | 67.5 | GO:0005925 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
| 0.2 | 2.9 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.2 | 0.3 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.2 | 1.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.2 | 0.3 | GO:0030315 | T-tubule(GO:0030315) |
| 0.2 | 3.9 | GO:0044453 | nuclear membrane part(GO:0044453) |
| 0.2 | 3.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.2 | 0.2 | GO:1990752 | microtubule end(GO:1990752) |
| 0.2 | 6.5 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 1.3 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 2.8 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
| 0.2 | 0.8 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.2 | 2.3 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.2 | 0.5 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.2 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.2 | 0.5 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.1 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.1 | 5.6 | GO:0045178 | basal part of cell(GO:0045178) |
| 0.1 | 1.6 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 1.2 | GO:0071203 | WASH complex(GO:0071203) |
| 0.1 | 0.4 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 0.7 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.1 | 1.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.1 | 3.0 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.1 | 1.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.1 | 2.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.1 | 13.0 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 0.6 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
| 0.1 | 0.1 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.1 | 0.4 | GO:0030017 | sarcomere(GO:0030017) |
| 0.1 | 0.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.1 | 2.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 8.1 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.1 | 0.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.1 | 0.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 1.8 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 0.1 | 5.3 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 0.4 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 0.8 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 1.2 | GO:0000801 | central element(GO:0000801) |
| 0.1 | 0.9 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 2.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.1 | 0.5 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.1 | 0.5 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 3.3 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.1 | 0.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.1 | 0.5 | GO:0071547 | piP-body(GO:0071547) |
| 0.1 | 0.6 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.1 | 21.3 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.2 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.1 | 1.5 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 22.1 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
| 0.1 | 0.7 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
| 0.1 | 1.8 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 0.2 | GO:0000229 | cytoplasmic chromosome(GO:0000229) |
| 0.1 | 0.5 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 7.9 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 1.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 0.6 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 0.1 | 3.5 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 0.3 | GO:0097539 | ciliary transition fiber(GO:0097539) |
| 0.1 | 2.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
| 0.1 | 0.4 | GO:0005694 | chromosome(GO:0005694) |
| 0.1 | 3.4 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 0.2 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.1 | 3.3 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 107.9 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 0.5 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 0.1 | 1.1 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 6.3 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.1 | 0.3 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 0.4 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 0.1 | 0.2 | GO:0031906 | late endosome lumen(GO:0031906) |
| 0.1 | 0.7 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.1 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 9.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.1 | 1.4 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.1 | 1.1 | GO:0098644 | complex of collagen trimers(GO:0098644) |
| 0.1 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.1 | 7.4 | GO:0031674 | I band(GO:0031674) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 1.1 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 0.1 | 0.1 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
| 0.1 | 4.2 | GO:0005912 | adherens junction(GO:0005912) anchoring junction(GO:0070161) |
| 0.1 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
| 0.1 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.1 | 0.3 | GO:0030137 | COPI-coated vesicle(GO:0030137) COPI-coated vesicle membrane(GO:0030663) |
| 0.1 | 0.6 | GO:0044437 | vacuolar part(GO:0044437) |
| 0.1 | 0.6 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 0.8 | GO:0031672 | A band(GO:0031672) |
| 0.1 | 1.9 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.1 | 12.0 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 3.3 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 0.1 | 0.3 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
| 0.1 | 0.7 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.1 | 0.2 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.1 | 1.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.1 | 0.2 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.1 | 2.0 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.1 | 0.4 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 0.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 1.2 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.1 | 0.1 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.1 | 1.5 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
| 0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 5.2 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.1 | 0.1 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.4 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.1 | 0.6 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 1.4 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.1 | 0.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.1 | 0.4 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.1 | 0.1 | GO:0043291 | RAVE complex(GO:0043291) |
| 0.1 | 14.0 | GO:0016324 | apical plasma membrane(GO:0016324) |
| 0.1 | 2.1 | GO:0005938 | cell cortex(GO:0005938) |
| 0.1 | 0.6 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
| 0.1 | 13.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.1 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.1 | 0.2 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.1 | 0.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
| 0.1 | 0.4 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.1 | 0.6 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.1 | 0.6 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 26.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 4.0 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
| 0.1 | 6.4 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.8 | GO:0000791 | euchromatin(GO:0000791) |
| 0.0 | 0.1 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
| 0.0 | 0.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
| 0.0 | 1.2 | GO:0022626 | cytosolic ribosome(GO:0022626) |
| 0.0 | 0.3 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
| 0.0 | 0.3 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 0.0 | 0.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.0 | 0.2 | GO:0005712 | chiasma(GO:0005712) |
| 0.0 | 11.4 | GO:0005874 | microtubule(GO:0005874) |
| 0.0 | 0.7 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.0 | 0.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.0 | 0.3 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.0 | 6.3 | GO:0015629 | actin cytoskeleton(GO:0015629) |
| 0.0 | 0.9 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.0 | 0.3 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
| 0.0 | 0.1 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.0 | 0.6 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.0 | 0.6 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.4 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 3.2 | GO:0000922 | spindle pole(GO:0000922) |
| 0.0 | 0.1 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 0.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
| 0.0 | 0.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.0 | 41.6 | GO:0005615 | extracellular space(GO:0005615) |
| 0.0 | 0.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
| 0.0 | 1.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.1 | GO:0034705 | potassium channel complex(GO:0034705) |
| 0.0 | 2.0 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.5 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
| 0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.0 | 0.0 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.0 | 0.0 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 0.0 | GO:0097179 | protease inhibitor complex(GO:0097179) |
| 0.0 | 0.1 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.0 | 2.2 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.0 | 0.2 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.0 | 0.1 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.0 | 0.5 | GO:0042581 | specific granule(GO:0042581) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 11.5 | 46.0 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 8.1 | 24.2 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 6.7 | 20.0 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
| 4.2 | 12.5 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
| 3.9 | 15.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 3.5 | 10.5 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
| 3.2 | 9.5 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
| 3.2 | 9.5 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
| 3.1 | 12.5 | GO:0030395 | lactose binding(GO:0030395) |
| 3.1 | 12.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 3.1 | 43.0 | GO:0031014 | troponin T binding(GO:0031014) |
| 3.0 | 11.9 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
| 2.9 | 14.3 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
| 2.7 | 8.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 2.4 | 7.3 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 2.4 | 2.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 2.4 | 9.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 2.4 | 14.2 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 2.4 | 11.8 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 2.3 | 9.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 2.2 | 19.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 2.1 | 8.4 | GO:0004329 | formate-tetrahydrofolate ligase activity(GO:0004329) |
| 2.1 | 8.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 2.1 | 6.2 | GO:0004797 | thymidine kinase activity(GO:0004797) |
| 2.1 | 12.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 2.1 | 6.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 2.0 | 10.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 2.0 | 9.9 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
| 1.9 | 5.7 | GO:0034189 | very-low-density lipoprotein particle binding(GO:0034189) |
| 1.9 | 26.5 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 1.9 | 9.4 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 1.9 | 5.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 1.9 | 18.7 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 1.8 | 7.4 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
| 1.8 | 3.7 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 1.8 | 18.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 1.8 | 9.0 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 1.8 | 9.0 | GO:0032810 | sterol response element binding(GO:0032810) |
| 1.8 | 7.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 1.8 | 5.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 1.8 | 8.8 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.7 | 17.5 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
| 1.7 | 3.5 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.7 | 1.7 | GO:0034452 | dynactin binding(GO:0034452) |
| 1.6 | 1.6 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
| 1.6 | 6.5 | GO:0004802 | transketolase activity(GO:0004802) |
| 1.6 | 4.8 | GO:0030984 | kininogen binding(GO:0030984) |
| 1.6 | 11.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 1.6 | 4.7 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 1.6 | 9.3 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.5 | 10.7 | GO:1990254 | keratin filament binding(GO:1990254) |
| 1.5 | 4.6 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
| 1.5 | 18.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 1.5 | 10.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
| 1.5 | 2.9 | GO:0002054 | nucleobase binding(GO:0002054) purine nucleobase binding(GO:0002060) |
| 1.5 | 8.7 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 1.4 | 8.7 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 1.4 | 21.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 1.4 | 4.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 1.4 | 8.5 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 1.4 | 5.6 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 1.4 | 4.2 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 1.4 | 6.8 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 1.4 | 5.4 | GO:0035501 | MH1 domain binding(GO:0035501) |
| 1.3 | 6.6 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 1.3 | 11.9 | GO:0043426 | MRF binding(GO:0043426) |
| 1.3 | 5.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
| 1.3 | 2.6 | GO:0038025 | reelin receptor activity(GO:0038025) |
| 1.3 | 3.9 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
| 1.3 | 14.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 1.3 | 14.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.3 | 1.3 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
| 1.3 | 5.0 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 1.3 | 5.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
| 1.2 | 6.2 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 1.2 | 4.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 1.2 | 4.9 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 1.2 | 4.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 1.2 | 3.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 1.2 | 3.6 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 1.2 | 7.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 1.2 | 1.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 1.2 | 8.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 1.2 | 7.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
| 1.2 | 3.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 1.2 | 5.9 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
| 1.2 | 4.7 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 1.2 | 9.3 | GO:0004064 | arylesterase activity(GO:0004064) |
| 1.2 | 7.0 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 1.2 | 18.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 1.1 | 9.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 1.1 | 2.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 1.1 | 4.6 | GO:1903135 | cupric ion binding(GO:1903135) |
| 1.1 | 10.2 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
| 1.1 | 10.0 | GO:0102337 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.1 | 3.3 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 1.1 | 5.5 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
| 1.1 | 4.4 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 1.1 | 3.3 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 1.1 | 4.3 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 1.0 | 4.2 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 1.0 | 10.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 1.0 | 10.4 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
| 1.0 | 2.1 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 1.0 | 13.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.0 | 4.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 1.0 | 4.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 1.0 | 3.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 1.0 | 10.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 1.0 | 7.0 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 1.0 | 5.0 | GO:0050436 | microfibril binding(GO:0050436) |
| 1.0 | 3.0 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
| 1.0 | 3.0 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 1.0 | 2.9 | GO:0035539 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) |
| 1.0 | 1.9 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
| 1.0 | 1.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.0 | 19.2 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 0.9 | 5.4 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.9 | 6.3 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.9 | 8.1 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.9 | 5.4 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.9 | 2.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.9 | 10.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.9 | 6.2 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
| 0.9 | 3.5 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
| 0.9 | 4.4 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 0.9 | 1.8 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
| 0.9 | 6.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
| 0.9 | 4.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.9 | 3.5 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
| 0.9 | 1.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.9 | 2.6 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
| 0.9 | 12.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.9 | 2.6 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 0.9 | 6.0 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.8 | 5.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.8 | 2.5 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
| 0.8 | 23.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.8 | 3.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
| 0.8 | 8.3 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.8 | 2.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
| 0.8 | 12.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
| 0.8 | 4.1 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.8 | 6.5 | GO:0005497 | androgen binding(GO:0005497) |
| 0.8 | 3.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
| 0.8 | 9.7 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.8 | 3.2 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.8 | 5.6 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.8 | 0.8 | GO:0043531 | ADP binding(GO:0043531) |
| 0.8 | 20.0 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.8 | 2.4 | GO:0032093 | SAM domain binding(GO:0032093) |
| 0.8 | 4.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.8 | 2.4 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 0.8 | 18.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.8 | 13.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.8 | 3.1 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.8 | 26.1 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.8 | 5.4 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.8 | 6.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.8 | 3.0 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
| 0.8 | 2.3 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 0.8 | 3.0 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.8 | 4.5 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
| 0.7 | 8.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.7 | 3.7 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.7 | 4.4 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.7 | 10.2 | GO:0089720 | caspase binding(GO:0089720) |
| 0.7 | 4.4 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.7 | 2.9 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.7 | 3.6 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.7 | 2.2 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
| 0.7 | 29.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.7 | 3.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.7 | 17.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.7 | 2.1 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
| 0.7 | 4.3 | GO:0052656 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.7 | 2.8 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
| 0.7 | 2.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.7 | 3.5 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.7 | 2.1 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
| 0.7 | 3.5 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
| 0.7 | 6.3 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.7 | 5.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
| 0.7 | 15.4 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.7 | 5.5 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 0.7 | 2.8 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.7 | 2.1 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.7 | 0.7 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
| 0.7 | 0.7 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.7 | 9.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 0.7 | 4.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.7 | 4.7 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.7 | 12.0 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
| 0.7 | 5.3 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.7 | 14.6 | GO:0019841 | retinol binding(GO:0019841) |
| 0.7 | 7.9 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 0.7 | 2.6 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.7 | 2.6 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.7 | 4.6 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 0.7 | 3.9 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.7 | 6.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
| 0.6 | 0.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.6 | 1.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 0.6 | 3.2 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.6 | 9.6 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.6 | 13.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.6 | 4.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.6 | 1.9 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
| 0.6 | 1.9 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 0.6 | 1.9 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.6 | 0.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
| 0.6 | 1.8 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
| 0.6 | 12.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.6 | 7.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.6 | 10.2 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.6 | 5.4 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.6 | 3.0 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
| 0.6 | 7.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.6 | 1.8 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.6 | 53.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.6 | 5.3 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.6 | 1.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.6 | 14.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.6 | 2.9 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
| 0.6 | 5.8 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.6 | 2.9 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.6 | 2.3 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
| 0.6 | 2.9 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.6 | 1.2 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.6 | 2.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.6 | 1.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.6 | 4.0 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
| 0.6 | 4.6 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.6 | 2.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
| 0.6 | 2.3 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.6 | 12.0 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.6 | 8.6 | GO:0048185 | activin binding(GO:0048185) |
| 0.6 | 0.6 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.6 | 2.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.6 | 6.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.6 | 10.1 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.6 | 1.7 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.6 | 2.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.6 | 9.4 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.5 | 3.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.5 | 2.7 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
| 0.5 | 14.1 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 0.5 | 3.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.5 | 6.0 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.5 | 3.2 | GO:0045569 | TRAIL binding(GO:0045569) |
| 0.5 | 3.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.5 | 1.6 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 0.5 | 4.2 | GO:0031432 | titin binding(GO:0031432) |
| 0.5 | 10.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.5 | 7.9 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.5 | 1.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.5 | 2.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
| 0.5 | 8.4 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.5 | 0.5 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.5 | 1.6 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 0.5 | 2.6 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
| 0.5 | 5.2 | GO:0005521 | lamin binding(GO:0005521) |
| 0.5 | 161.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.5 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.5 | 0.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
| 0.5 | 6.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
| 0.5 | 1.5 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.5 | 1.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.5 | 1.5 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.5 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 0.5 | 15.7 | GO:0043236 | laminin binding(GO:0043236) |
| 0.5 | 1.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.5 | 0.5 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.5 | 2.0 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.5 | 3.0 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.5 | 9.9 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
| 0.5 | 9.9 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.5 | 3.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 0.5 | 2.0 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 0.5 | 2.5 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
| 0.5 | 1.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
| 0.5 | 1.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.5 | 5.9 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 0.5 | 3.4 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.5 | 2.5 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.5 | 2.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.5 | 1.5 | GO:0002113 | interleukin-33 binding(GO:0002113) |
| 0.5 | 1.5 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.5 | 2.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.5 | 1.0 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.5 | 2.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.5 | 6.3 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.5 | 2.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.5 | 3.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.5 | 1.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 0.5 | 3.8 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.5 | 4.3 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.5 | 5.7 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.5 | 6.7 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.5 | 1.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
| 0.5 | 9.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.5 | 1.9 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
| 0.5 | 8.9 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
| 0.5 | 1.4 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.5 | 2.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.5 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.5 | 1.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.5 | 1.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 0.5 | 1.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
| 0.5 | 0.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.5 | 6.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
| 0.5 | 1.4 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.5 | 4.1 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.5 | 0.5 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.5 | 1.4 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
| 0.5 | 5.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
| 0.5 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.5 | 4.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
| 0.5 | 0.5 | GO:0000035 | acyl binding(GO:0000035) |
| 0.5 | 9.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.4 | 8.1 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
| 0.4 | 1.3 | GO:0005112 | Notch binding(GO:0005112) |
| 0.4 | 1.3 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
| 0.4 | 7.1 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.4 | 1.8 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.4 | 4.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.4 | 7.5 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.4 | 1.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.4 | 2.7 | GO:0016672 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
| 0.4 | 0.4 | GO:0043566 | structure-specific DNA binding(GO:0043566) |
| 0.4 | 2.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
| 0.4 | 0.9 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
| 0.4 | 24.0 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
| 0.4 | 4.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.4 | 195.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.4 | 8.6 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.4 | 4.7 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.4 | 1.3 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.4 | 3.8 | GO:0005536 | glucose binding(GO:0005536) |
| 0.4 | 1.3 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
| 0.4 | 10.2 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
| 0.4 | 1.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.4 | 3.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.4 | 18.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.4 | 11.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.4 | 6.7 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.4 | 1.6 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
| 0.4 | 1.2 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.4 | 1.6 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
| 0.4 | 0.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.4 | 2.0 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.4 | 3.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
| 0.4 | 0.8 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.4 | 1.2 | GO:0032440 | 2-alkenal reductase [NAD(P)] activity(GO:0032440) |
| 0.4 | 1.2 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
| 0.4 | 2.0 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
| 0.4 | 4.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.4 | 2.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.4 | 0.8 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.4 | 0.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.4 | 1.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 0.4 | 3.2 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.4 | 1.6 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
| 0.4 | 20.1 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.4 | 2.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
| 0.4 | 2.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.4 | 0.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.4 | 1.2 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
| 0.4 | 1.9 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.4 | 10.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.4 | 7.8 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.4 | 0.4 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
| 0.4 | 7.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.4 | 1.5 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.4 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.4 | 3.1 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.4 | 5.0 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.4 | 2.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.4 | 0.4 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
| 0.4 | 8.3 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 2.3 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.4 | 1.9 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 0.4 | 1.1 | GO:0008386 | cholesterol monooxygenase (side-chain-cleaving) activity(GO:0008386) |
| 0.4 | 1.5 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.4 | 0.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
| 0.4 | 0.7 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.4 | 5.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.4 | 1.1 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.4 | 1.1 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 0.4 | 3.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.4 | 5.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.4 | 5.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.4 | 1.1 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.4 | 1.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.4 | 3.2 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 2.1 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.4 | 36.2 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.4 | 4.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.4 | 3.2 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.4 | 2.5 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.4 | 1.8 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
| 0.3 | 1.4 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
| 0.3 | 9.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.3 | 2.8 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
| 0.3 | 4.8 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.3 | 1.0 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.3 | 3.8 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.3 | 2.4 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
| 0.3 | 7.1 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.3 | 2.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
| 0.3 | 1.0 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
| 0.3 | 1.7 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
| 0.3 | 1.0 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 0.3 | 1.0 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.3 | 1.0 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
| 0.3 | 0.6 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
| 0.3 | 17.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.3 | 3.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.3 | 1.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.3 | 1.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.3 | 14.0 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.3 | 0.9 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 0.3 | 0.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.3 | 3.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.3 | 3.1 | GO:0015288 | porin activity(GO:0015288) |
| 0.3 | 0.3 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
| 0.3 | 4.3 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.3 | 0.9 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.3 | 1.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.3 | 34.0 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.3 | 4.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.3 | 1.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.3 | 1.8 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.3 | 19.8 | GO:0019003 | GDP binding(GO:0019003) |
| 0.3 | 0.3 | GO:0030546 | receptor activator activity(GO:0030546) |
| 0.3 | 0.6 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.3 | 3.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.3 | 5.0 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.3 | 1.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
| 0.3 | 8.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.3 | 2.9 | GO:0032190 | acrosin binding(GO:0032190) |
| 0.3 | 1.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.3 | 32.4 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.3 | 1.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.3 | 2.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
| 0.3 | 1.1 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.3 | 0.3 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 0.3 | 2.0 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.3 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.3 | 1.7 | GO:0052842 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
| 0.3 | 1.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.3 | 5.5 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.3 | 0.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.3 | 0.6 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.3 | 2.7 | GO:0031078 | NAD-dependent histone deacetylase activity(GO:0017136) histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) NAD-dependent protein deacetylase activity(GO:0034979) |
| 0.3 | 3.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.3 | 0.3 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.3 | 6.3 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
| 0.3 | 0.8 | GO:0031403 | pyridoxal kinase activity(GO:0008478) lithium ion binding(GO:0031403) |
| 0.3 | 0.8 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
| 0.3 | 1.1 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.3 | 9.2 | GO:0004622 | lysophospholipase activity(GO:0004622) |
| 0.3 | 71.8 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.3 | 2.1 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.3 | 2.7 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.3 | 1.9 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.3 | 0.8 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.3 | 0.8 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
| 0.3 | 0.8 | GO:0047150 | betaine-homocysteine S-methyltransferase activity(GO:0047150) |
| 0.3 | 1.0 | GO:0004998 | transferrin receptor activity(GO:0004998) |
| 0.3 | 6.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.3 | 6.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.3 | 3.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 0.3 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
| 0.3 | 2.3 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.3 | 6.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.3 | 3.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.3 | 0.3 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
| 0.3 | 0.5 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.3 | 1.0 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
| 0.3 | 0.8 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.3 | 1.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 0.5 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
| 0.2 | 1.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.2 | 0.5 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.2 | 1.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.2 | 2.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.2 | 1.0 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.2 | 1.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.2 | 1.7 | GO:0070728 | leucine binding(GO:0070728) |
| 0.2 | 1.2 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.2 | 1.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.2 | 1.0 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.2 | 0.7 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 0.2 | 2.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 1.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 0.7 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.2 | 1.4 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 0.2 | 1.0 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
| 0.2 | 1.2 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 5.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 1.4 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.2 | 0.7 | GO:0004913 | interleukin-4 receptor activity(GO:0004913) |
| 0.2 | 15.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.2 | 2.1 | GO:0055106 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.2 | 1.2 | GO:0015295 | solute:proton symporter activity(GO:0015295) |
| 0.2 | 0.7 | GO:0097259 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
| 0.2 | 0.9 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.2 | 0.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.2 | 19.1 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.2 | 0.7 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.2 | 3.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
| 0.2 | 1.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.2 | 0.7 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.2 | 0.5 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
| 0.2 | 5.7 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 1.4 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.2 | 0.2 | GO:0001003 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 0.2 | 0.2 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
| 0.2 | 2.0 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.2 | 3.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
| 0.2 | 0.7 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
| 0.2 | 10.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.2 | 0.2 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.2 | 2.9 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.2 | 1.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.2 | 2.4 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
| 0.2 | 6.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
| 0.2 | 0.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.2 | 32.5 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.2 | 0.9 | GO:0042910 | xenobiotic-transporting ATPase activity(GO:0008559) xenobiotic transporter activity(GO:0042910) |
| 0.2 | 91.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
| 0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
| 0.2 | 0.9 | GO:0004966 | galanin receptor activity(GO:0004966) |
| 0.2 | 3.9 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.2 | 0.9 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 0.2 | 0.4 | GO:0008252 | nucleotidase activity(GO:0008252) |
| 0.2 | 1.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
| 0.2 | 3.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 0.2 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.2 | 1.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.2 | 3.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.2 | 0.6 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
| 0.2 | 0.8 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
| 0.2 | 0.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 0.8 | GO:0004882 | androgen receptor activity(GO:0004882) |
| 0.2 | 18.5 | GO:0030674 | protein binding, bridging(GO:0030674) |
| 0.2 | 0.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.2 | 0.6 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 5.7 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.2 | 1.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.2 | 1.2 | GO:0051880 | G-quadruplex DNA binding(GO:0051880) |
| 0.2 | 19.7 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.2 | 0.6 | GO:0046790 | virion binding(GO:0046790) |
| 0.2 | 2.8 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
| 0.2 | 0.4 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.2 | 1.4 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.2 | 0.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
| 0.2 | 5.5 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.2 | 5.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.2 | 0.4 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.2 | 0.6 | GO:0004324 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.2 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.2 | 1.9 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.2 | 3.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.2 | 2.5 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.2 | 1.3 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.2 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 0.2 | 0.6 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 0.2 | 1.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
| 0.2 | 1.7 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 0.2 | 2.8 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.2 | 1.3 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 21.9 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
| 0.2 | 1.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.2 | 0.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.2 | 0.2 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.2 | 4.4 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.2 | 3.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
| 0.2 | 3.6 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 0.7 | GO:0097604 | temperature-gated cation channel activity(GO:0097604) |
| 0.2 | 1.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
| 0.2 | 1.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.2 | 0.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.2 | 1.1 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
| 0.2 | 6.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.2 | 1.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.2 | 1.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.2 | 2.3 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.2 | 2.3 | GO:0033691 | sialic acid binding(GO:0033691) |
| 0.2 | 1.4 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 3.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
| 0.2 | 3.5 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.2 | 0.3 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
| 0.2 | 7.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
| 0.2 | 6.7 | GO:0019902 | phosphatase binding(GO:0019902) |
| 0.2 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 1.9 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.2 | 2.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
| 0.2 | 2.9 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.2 | 18.2 | GO:0002020 | protease binding(GO:0002020) |
| 0.2 | 0.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.2 | 0.8 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.2 | 1.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.2 | 0.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 1.8 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 0.7 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 0.2 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
| 0.2 | 1.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 0.2 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.2 | 1.0 | GO:0042835 | BRE binding(GO:0042835) |
| 0.2 | 0.5 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
| 0.2 | 0.3 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.2 | 0.7 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.2 | 0.8 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
| 0.2 | 8.1 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.2 | 0.5 | GO:0004020 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
| 0.2 | 4.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.2 | 0.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.2 | 1.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.2 | 2.1 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.2 | 7.6 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
| 0.2 | 3.8 | GO:0030291 | protein serine/threonine kinase inhibitor activity(GO:0030291) |
| 0.2 | 2.2 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.2 | 3.4 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.2 | 1.1 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
| 0.2 | 0.8 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
| 0.2 | 2.3 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
| 0.2 | 4.1 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
| 0.2 | 3.0 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.2 | 0.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 0.7 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.1 | 0.1 | GO:0045295 | gamma-catenin binding(GO:0045295) |
| 0.1 | 2.3 | GO:0070325 | lipoprotein particle receptor binding(GO:0070325) |
| 0.1 | 0.9 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.1 | 1.8 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.1 | 0.1 | GO:0019955 | cytokine binding(GO:0019955) |
| 0.1 | 0.6 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.1 | 0.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
| 0.1 | 0.4 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.1 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.1 | 0.8 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
| 0.1 | 4.8 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 0.1 | 9.7 | GO:0035064 | methylated histone binding(GO:0035064) |
| 0.1 | 0.1 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
| 0.1 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
| 0.1 | 0.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.1 | 0.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
| 0.1 | 3.6 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.1 | 1.7 | GO:0030284 | estrogen receptor activity(GO:0030284) |
| 0.1 | 1.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
| 0.1 | 0.4 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 0.1 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.1 | 5.4 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.1 | 0.6 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.1 | 0.8 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 0.1 | 2.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 0.3 | GO:0033265 | choline binding(GO:0033265) |
| 0.1 | 0.9 | GO:0019838 | growth factor binding(GO:0019838) |
| 0.1 | 3.0 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.1 | 3.6 | GO:0017016 | Ras GTPase binding(GO:0017016) |
| 0.1 | 0.4 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.1 | 1.1 | GO:0004985 | opioid receptor activity(GO:0004985) |
| 0.1 | 0.1 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.1 | 0.3 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
| 0.1 | 0.3 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.1 | 0.4 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.1 | 4.2 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
| 0.1 | 0.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.1 | 0.5 | GO:0034584 | piRNA binding(GO:0034584) |
| 0.1 | 4.6 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.1 | 0.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.1 | 0.6 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.1 | 1.4 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.3 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 0.6 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.1 | 0.4 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
| 0.1 | 3.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 2.2 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.7 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.1 | 0.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 1.2 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 1.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 11.3 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 0.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.6 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 2.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 0.7 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 0.1 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.1 | 0.5 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.1 | 2.0 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
| 0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.1 | 0.5 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.1 | 0.1 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
| 0.1 | 0.3 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.1 | 1.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.1 | 0.3 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.1 | 0.7 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
| 0.1 | 0.8 | GO:0030267 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.1 | 0.1 | GO:0019209 | kinase activator activity(GO:0019209) |
| 0.1 | 3.7 | GO:0017048 | Rho GTPase binding(GO:0017048) |
| 0.1 | 3.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 0.2 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 8.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
| 0.1 | 0.9 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.1 | 0.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
| 0.1 | 2.9 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.1 | 0.3 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
| 0.1 | 1.5 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.1 | 0.9 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 1.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 1.4 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 2.9 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.1 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
| 0.1 | 0.3 | GO:0016877 | ligase activity, forming carbon-sulfur bonds(GO:0016877) |
| 0.1 | 0.3 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.3 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 0.7 | GO:0070739 | protein-glutamic acid ligase activity(GO:0070739) |
| 0.1 | 1.5 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
| 0.1 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.3 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.3 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.1 | 0.2 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.1 | 5.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.1 | 0.4 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.1 | 0.2 | GO:0035240 | dopamine binding(GO:0035240) |
| 0.1 | 3.3 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.5 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
| 0.1 | 1.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.1 | 6.1 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.1 | 0.4 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 0.1 | 0.3 | GO:0005272 | sodium channel activity(GO:0005272) |
| 0.1 | 8.1 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
| 0.1 | 0.3 | GO:0000994 | RNA polymerase III core binding(GO:0000994) |
| 0.1 | 0.8 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.1 | 2.0 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 0.3 | GO:0004962 | endothelin receptor activity(GO:0004962) |
| 0.1 | 0.1 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 0.1 | 1.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.1 | 1.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.1 | 1.2 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.4 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.1 | 3.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
| 0.1 | 0.9 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
| 0.1 | 0.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.1 | 2.9 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.1 | 7.4 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.2 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 6.1 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
| 0.1 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
| 0.1 | 0.7 | GO:0036122 | BMP binding(GO:0036122) |
| 0.1 | 8.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.1 | 0.4 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.1 | 0.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
| 0.1 | 0.9 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.1 | 1.4 | GO:0005549 | odorant binding(GO:0005549) |
| 0.1 | 0.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 1.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.1 | 1.2 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
| 0.1 | 1.3 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
| 0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.1 | 0.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
| 0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.1 | 0.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.1 | 1.0 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.1 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.1 | 1.6 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.1 | 0.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
| 0.1 | 0.6 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
| 0.1 | 0.2 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.2 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 0.3 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.1 | 0.4 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.1 | 0.1 | GO:0044548 | S100 protein binding(GO:0044548) |
| 0.1 | 0.3 | GO:0097110 | scaffold protein binding(GO:0097110) |
| 0.1 | 0.3 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 0.2 | GO:0001076 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) |
| 0.1 | 0.2 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 0.1 | GO:0005221 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
| 0.1 | 1.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 0.3 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.1 | 0.7 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.1 | 1.5 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.1 | 0.5 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 0.8 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 0.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.3 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 0.1 | 0.4 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.1 | 0.4 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
| 0.1 | 0.2 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
| 0.1 | 0.2 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
| 0.1 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
| 0.1 | 0.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.1 | 0.2 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.1 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.1 | 0.2 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
| 0.1 | 1.4 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 0.1 | GO:0030613 | oxidoreductase activity, acting on phosphorus or arsenic in donors(GO:0030613) oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor(GO:0030614) |
| 0.1 | 0.5 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.1 | 0.2 | GO:0004057 | arginyltransferase activity(GO:0004057) |
| 0.1 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
| 0.1 | 0.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 0.3 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 0.1 | 0.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
| 0.1 | 1.5 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.1 | 0.1 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.2 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
| 0.1 | 0.1 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 0.1 | 2.8 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.1 | 0.6 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.1 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
| 0.0 | 0.3 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.0 | 0.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.0 | 0.0 | GO:0004951 | cholecystokinin receptor activity(GO:0004951) |
| 0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.0 | 0.5 | GO:0048018 | receptor agonist activity(GO:0048018) |
| 0.0 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
| 0.0 | 0.7 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
| 0.0 | 0.2 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.0 | 1.4 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.0 | 0.2 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.0 | 0.3 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.0 | 0.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.0 | 0.8 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.0 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.0 | 0.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 0.0 | 0.8 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.2 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 0.0 | 0.0 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.0 | 0.1 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.0 | 1.8 | GO:0003684 | damaged DNA binding(GO:0003684) |
| 0.0 | 0.1 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
| 0.0 | 0.2 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.0 | 0.5 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
| 0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
| 0.0 | 0.1 | GO:0070404 | NADH binding(GO:0070404) |
| 0.0 | 0.1 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.0 | 0.1 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.4 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.0 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.0 | 0.2 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.0 | 0.1 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.0 | 0.1 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.0 | 0.1 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
| 0.0 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
| 0.0 | 0.1 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.0 | 5.9 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.0 | 0.1 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.0 | 0.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.0 | 0.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.0 | 0.7 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.0 | 0.1 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.0 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.0 | 0.3 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 0.0 | 0.0 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.0 | 0.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.0 | 0.0 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
| 0.0 | 0.1 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.0 | 0.2 | GO:0035586 | purinergic receptor activity(GO:0035586) |
| 0.0 | 0.4 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
| 0.0 | 0.5 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 0.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.1 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.0 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 0.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.0 | 0.0 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.9 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
| 0.0 | 0.2 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.0 | 0.8 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.0 | 0.1 | GO:0001861 | complement component C4b binding(GO:0001855) complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 0.0 | 0.1 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.0 | 1.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.0 | 0.7 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.3 | GO:0019843 | rRNA binding(GO:0019843) |
| 0.0 | 0.1 | GO:0046972 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
| 0.0 | 0.0 | GO:0097016 | L27 domain binding(GO:0097016) |
| 0.0 | 0.1 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 0.7 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.0 | 0.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.0 | 0.1 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.0 | 0.1 | GO:0030305 | heparanase activity(GO:0030305) |
| 0.0 | 0.1 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.0 | 0.0 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.0 | 0.3 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.0 | 0.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.0 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.6 | 21.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 1.5 | 28.0 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 1.2 | 1.2 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
| 1.1 | 34.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
| 1.0 | 76.9 | PID AURORA B PATHWAY | Aurora B signaling |
| 1.0 | 17.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 1.0 | 22.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.0 | 65.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.9 | 54.8 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.8 | 13.8 | PID IL5 PATHWAY | IL5-mediated signaling events |
| 0.8 | 7.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.8 | 45.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.7 | 32.7 | PID IFNG PATHWAY | IFN-gamma pathway |
| 0.7 | 32.3 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.7 | 7.0 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.6 | 1.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.6 | 4.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.6 | 16.5 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.5 | 17.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.5 | 9.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.5 | 15.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.5 | 48.1 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.5 | 27.7 | PID PLK1 PATHWAY | PLK1 signaling events |
| 0.5 | 25.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 0.5 | 14.7 | ST G ALPHA I PATHWAY | G alpha i Pathway |
| 0.5 | 35.0 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.5 | 8.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
| 0.5 | 21.3 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.5 | 10.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.5 | 17.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 0.5 | 1.9 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.5 | 25.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.5 | 9.2 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.4 | 0.9 | PID S1P S1P3 PATHWAY | S1P3 pathway |
| 0.4 | 9.8 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.4 | 15.3 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
| 0.4 | 43.8 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.4 | 2.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
| 0.4 | 2.5 | PID MYC PATHWAY | C-MYC pathway |
| 0.4 | 7.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.4 | 7.1 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.4 | 4.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.4 | 5.8 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.4 | 120.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.4 | 20.1 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.4 | 4.9 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.4 | 4.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.4 | 0.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.4 | 7.7 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.3 | 4.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
| 0.3 | 2.1 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.3 | 3.6 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.3 | 4.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.3 | 19.6 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.3 | 8.2 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.3 | 15.7 | PID CDC42 PATHWAY | CDC42 signaling events |
| 0.3 | 14.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.3 | 0.6 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.3 | 7.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.3 | 10.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.3 | 5.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.3 | 4.6 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.3 | 8.3 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.3 | 16.8 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.3 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.3 | 10.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.3 | 7.4 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.2 | 2.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
| 0.2 | 3.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
| 0.2 | 5.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.2 | 2.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 0.2 | 2.5 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.2 | 3.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 2.9 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
| 0.2 | 2.7 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
| 0.2 | 4.9 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.2 | 1.6 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
| 0.2 | 6.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.2 | 0.9 | ST GAQ PATHWAY | G alpha q Pathway |
| 0.2 | 1.9 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.2 | 7.9 | PID ATR PATHWAY | ATR signaling pathway |
| 0.2 | 8.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
| 0.2 | 0.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 1.6 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.2 | 2.9 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.2 | 3.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 1.0 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.2 | 1.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.2 | 6.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
| 0.2 | 0.9 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.2 | 1.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.2 | 2.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.2 | 16.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 3.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.2 | 4.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
| 0.2 | 2.7 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 2.1 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.2 | 6.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 3.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.2 | 0.3 | PID IGF1 PATHWAY | IGF1 pathway |
| 0.2 | 13.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 6.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 2.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 4.2 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 3.7 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.1 | 45.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 5.2 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 7.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.1 | 17.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.1 | 2.1 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 0.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 2.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 4.8 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 1.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.1 | 1.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 6.6 | PID E2F PATHWAY | E2F transcription factor network |
| 0.1 | 0.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 2.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.1 | 0.6 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
| 0.1 | 0.1 | PID REELIN PATHWAY | Reelin signaling pathway |
| 0.1 | 1.8 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.1 | 2.3 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.1 | 0.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
| 0.1 | 0.1 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.1 | 1.2 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 2.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.0 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
| 0.0 | 1.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.0 | 1.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
| 0.0 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.0 | 1.1 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
| 0.0 | 0.2 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 0.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
| 0.0 | 0.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 9.5 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 2.2 | 26.9 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 2.2 | 2.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
| 1.7 | 3.3 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 1.6 | 11.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 1.5 | 36.4 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 1.5 | 24.7 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
| 1.3 | 4.0 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 1.3 | 1.3 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
| 1.3 | 1.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
| 1.2 | 87.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.2 | 45.5 | REACTOME KINESINS | Genes involved in Kinesins |
| 1.2 | 12.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 1.1 | 36.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 1.1 | 21.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 1.1 | 1.1 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 1.1 | 23.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 1.1 | 17.0 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 1.1 | 30.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 1.0 | 24.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 1.0 | 45.6 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 0.9 | 10.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.9 | 6.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.9 | 18.0 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
| 0.8 | 27.1 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.8 | 27.8 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 0.8 | 18.3 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.8 | 37.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
| 0.8 | 18.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.8 | 14.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
| 0.8 | 25.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
| 0.8 | 12.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.7 | 19.5 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.7 | 13.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 0.7 | 22.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.7 | 17.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 0.7 | 17.7 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.7 | 11.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.7 | 6.2 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
| 0.7 | 9.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.7 | 25.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.7 | 19.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.7 | 13.1 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
| 0.6 | 12.3 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.6 | 3.9 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.6 | 6.4 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
| 0.6 | 15.2 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.6 | 18.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
| 0.6 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.6 | 17.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.6 | 7.0 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.6 | 18.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.6 | 12.5 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.6 | 3.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
| 0.5 | 9.6 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.5 | 10.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.5 | 4.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.5 | 10.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
| 0.5 | 53.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
| 0.5 | 20.1 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
| 0.5 | 2.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
| 0.5 | 2.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.5 | 16.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.5 | 1.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 0.5 | 26.2 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
| 0.4 | 9.9 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
| 0.4 | 20.1 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.4 | 5.9 | REACTOME OPSINS | Genes involved in Opsins |
| 0.4 | 5.0 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
| 0.4 | 9.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.4 | 8.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.4 | 8.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.4 | 27.3 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.4 | 1.9 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 0.4 | 7.2 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
| 0.4 | 3.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 0.4 | 4.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 0.4 | 2.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
| 0.4 | 8.2 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 6.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.4 | 3.3 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.4 | 1.8 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
| 0.4 | 2.9 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.4 | 18.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 0.3 | 5.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.3 | 7.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.3 | 5.2 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.3 | 7.8 | REACTOME G2 M CHECKPOINTS | Genes involved in G2/M Checkpoints |
| 0.3 | 21.6 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.3 | 16.5 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
| 0.3 | 10.2 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.3 | 6.6 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.3 | 13.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 8.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.3 | 6.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.3 | 5.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.3 | 4.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.3 | 1.8 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
| 0.3 | 0.3 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.3 | 7.9 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.3 | 1.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
| 0.3 | 10.8 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.3 | 1.5 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.3 | 3.2 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.3 | 22.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.3 | 8.1 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.3 | 6.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.3 | 5.7 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
| 0.3 | 11.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.3 | 3.0 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.3 | 7.0 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.3 | 8.0 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.3 | 11.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.3 | 14.5 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.3 | 4.1 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.3 | 6.9 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.3 | 11.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 0.2 | 4.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 3.6 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
| 0.2 | 32.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.2 | 3.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
| 0.2 | 2.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
| 0.2 | 1.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.2 | 3.5 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
| 0.2 | 2.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.2 | 0.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
| 0.2 | 7.4 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.2 | 7.8 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.2 | 5.1 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.2 | 0.4 | REACTOME CELL CELL COMMUNICATION | Genes involved in Cell-Cell communication |
| 0.2 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.2 | 3.5 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
| 0.2 | 3.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.2 | 5.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.2 | 4.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 2.1 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 5.7 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
| 0.2 | 2.2 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.2 | 4.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.2 | 4.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 1.8 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 0.4 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.2 | 4.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
| 0.2 | 0.9 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.2 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
| 0.2 | 4.1 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 0.2 | 5.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.2 | 2.7 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
| 0.2 | 0.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
| 0.2 | 0.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 0.2 | 3.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.2 | 4.4 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
| 0.2 | 5.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
| 0.2 | 2.0 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.1 | 0.3 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.1 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 2.2 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.1 | 7.9 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
| 0.1 | 0.3 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
| 0.1 | 3.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
| 0.1 | 2.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 4.0 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 0.1 | 1.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 1.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 3.6 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
| 0.1 | 1.5 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
| 0.1 | 5.4 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.1 | 3.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 0.8 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
| 0.1 | 10.0 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
| 0.1 | 1.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 0.8 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
| 0.1 | 2.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.1 | 0.4 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 0.1 | 1.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 0.1 | 6.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 0.5 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
| 0.1 | 15.0 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 0.1 | 1.4 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
| 0.1 | 8.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.1 | 1.8 | REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE | Genes involved in NFkB and MAP kinases activation mediated by TLR4 signaling repertoire |
| 0.1 | 2.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 2.4 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.1 | 2.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 0.1 | 2.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.1 | 1.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
| 0.1 | 4.8 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 2.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
| 0.1 | 11.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 0.9 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 0.4 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 2.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 2.7 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
| 0.1 | 0.4 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
| 0.1 | 7.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
| 0.1 | 0.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 3.3 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 0.5 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
| 0.1 | 1.1 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
| 0.1 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
| 0.1 | 1.3 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 0.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 0.1 | 4.2 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.1 | 2.2 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
| 0.1 | 1.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 0.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 0.1 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.1 | 14.2 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.1 | 1.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
| 0.1 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.1 | 3.1 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 3.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.0 | 0.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.0 | 1.0 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 0.0 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.0 | 0.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.0 | 0.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.0 | 0.2 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.0 | 0.6 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.0 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.0 | 0.2 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.0 | 0.1 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
| 0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.0 | 0.2 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.0 | 2.0 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |